Comparative studies directed towards the bioactivity evaluation of Iris species for prospective resourcing as therapeutic agents by Buchh, Soubiya & Qurishi, M.A (Guide)
  
Comparative studies directed towards the bioactivity evaluation 
of Iris species for prospective resourcing as therapeutic agents 
 
 
DISSERTATION 
 
SUBMITTED IN PARTIAL FULFILMENT OF THE REQUIREMENTS 
PROVIDED FOR THE AWARD OF DEGREE OF 
 
MASTER OF PHILOSOPHY 
IN 
CHEMISTRY 
BY 
SOUBIYA MUKHTAR BUCHH 
Under the supervision of 
Prof M A Qurishi  
 
 
 
           
 
 
 
 
 
 
 
 
 
 
DEPARTMENT OF CHEMISTRY 
UNIVERSITY OF KASHMIR 
SRINAGAR (J&K) INDIA 190 006 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DEDICATED 
 
TO 
 
MY BELOVED PARENTS 
 
FOR 
 
THEIR LOVE AND PRAYERS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                     Department of Chemistry,  
  University of Kashmir, Srinagar-190 006 
 
 
Certificate 
 
 
This is to certify that the work presented in this dissertation entitled Comparative 
studies directed towards the bioactivity evaluation of Iris species for prospective 
resourcing as therapeutic agents is original and has been carried out by Ms 
Soubiya Mukhtar Buchh under my supervision. This work is suitable for submission 
for the award of M.Phil Degree in Chemistry. It is further certified that the work has 
not been submitted in part or full for award of any degree in this or any other 
University. 
 
 
 
Prof M A Qurishi 
                                         
       Department of Chemistry 
University of Kashmir, Srinagar 190 006 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Department of Chemistry, 
University of Kashmir, Srinagar-190 006 
                               
Declaration 
      
I hereby declare that the work incorporated in this dissertation entitled 
Comparative studies directed towards the bioactivity evaluation of Iris species 
for prospective resourcing as therapeutic agents under the supervision of Prof. M. 
A. Qurishi    submitted for Mphil degree was carried out by me in the 
Department of Chemistry, University of Kashmir, Srinagar-190006, J&K. The 
entire work or any part of it has never been submitted before for any prize or 
degree anywhere. 
  
 
 
Dated: 
         Soubiya Mukhtar 
 
 
 
 
 
 
 ACKNOWLEDGEMENTS 
 
Blessed are the people whom Almighty Allah chooses to reach the highest seat of learning 
and I feel highly elated to consider myself as one of them. The journey of life including academic 
one becomes simpler, easy and successful, provided we have someone to guide and even assist at all 
occasions. To pursue the Master’s in philosophy and onwards was just like a colorful, pleasant and 
fragrant dream symbolized by a black rose lying at the end of a path full of prickles, thorns and 
spines. But Allah bestowed His blessings on me by providing a dedicated and selfless guide, Prof. 
M. A. Qurishi. It his able and excellent guidance which made this journey not only fragrant and 
colorful but even successful. Had he not guided and cared, my dream would have remained only a 
dream. 
A journey is easier when we travel together. This dissertation embodies the results of last 
years’ work whereby I have been accompanied and supported by many people. It is an honor and 
very pleasant opportunity to be able to express my gratitude to all of them. 
I invariably fall short of words to express my heartfelt gratitude to my great teacher Prof 
G. M. Peerzada, Head of the department, Department of Chemistry, University of Kashmir and 
encouraging support from prof Khaliquz Zaman, former HOD of the department of Chemistry. 
It has been a privilege to work under the dynamic leadership and guidance of my teachers 
Dr. Syed wajahat Amin Shah, Associate Professor, University of Kashmir, Prof Mohd Akbar 
Khuroo, Professor, University of Kashmir and Dr Ajaz Ahmad Dar, Associate Professor, 
University of Kashmir. Their unerring support, coherence of scientific thoughts and remarkable 
presence of mind propelled me through my scholarly tenure to move forward during the finest 
moments and the darkest hours. I am highly thankful to them for showing me the fourth 
dimension of life called ‘Science’. 
I would like to express humble thanks to Dr Anzar A Khuroo and Mr Akhtar  
department of taxonomy, university of Kashmir. 
I wish to express my deep sense of appreciation and gratitude to my senior colleagues Ms 
kurat ul ain, Mr Yusuf Ahmad Dar, Mr. Mubashir Sofi, Mr Aijaz ahmad, Mr S Raashid 
Maqsood and Mr Oyais A Chat for their generous help, critical suggestions and able guidance. I 
thank them for their painstaking efforts to nourish me through their advice and pulling me 
whenever I drowned in the abyssal deeps of hopelessness. 
I sincerely thank all my colleagues and friends at University of Kashmir for their 
camaraderie and constant support. My special thanks to Ms Shaista Nazir, Ms Saima Shafi, Ms 
Roohena Jan, Ms Uzma for always wearing a smile and helping me whenever necessary; that 
which sustained me and my search.  Their assistance during the tenure of my work is gratefully 
acknowledged. 
It is pleasure to thankfully acknowledge the scientists and colleagues of IIIM, Jammu 
particularly Mr Saleem Forooq and Mrs Yasrib Qurishi. 
Whatever good I have in my life is a result of immense sacrifices made by my parents. I 
have no words to express my heartfelt gratitude and respect towards my parents for their blessings, 
endless love and constant inspiration throughout my studies and for teaching me the essence of 
education and integrity. I offer hearty thanks to my beloved sister Ifrah and brother Shuja whose 
unconditional love and affection has always been my strength. 
   
  Soubiya Mukhtar 
 
 
 
 
                                           
CONTENTS 
Page no. 
Chapter 1: Introduction 
1.1. Natural product and drug discovery    1-2 
1.2. Folklore approach to pharmaceutical drug discovery  2-5 
1.3. Current status of natural product research   6-7 
1.4. Flavonoids- An overview             7-15 
1.5. Genus Iris              16-17 
         1.5.1. Isoflavones and their glycosides        17-21 
1.5.2. Chemical and spectral methods of characterisation                       
of isoflavones                     22-24 
1.5.3. Spectral properties of isoflavones        24-25 
1.5.4. Biological properties of isoflavones        25-27 
 
Chapter 2: Review of literature          28-32 
   2.1. Objectives for undertaking studies of Iris ensata and                        
Iris hookeriana                                                 32-33 
Chapter 3: Bioactivity evaluation of extracts of Iris ensata   
             3.1. Antitumor activity of rhizomes of Iris ensata      34-35 
             3.2. Antioxidant activity of rhizomes of Iris ensata      36-37 
             3.3. Antimicrobial activity of rhizomes of Iris ensata      37-38 
             3.4. Antitumor activity of leaves of Iris ensata       38-39 
             3.5. Antioxidant activity of leaves of Iris ensata      39-41 
             3.6. Antimicrobial activity of leaves of Iris ensata  41 
 
 
Chapter 4: Bioactivity evaluation of extracts of Iris hookeriana  
             4.1. Antitumor activity of rhizomes of Iris hookeriana    42-43 
             4.2. Antioxidant activity of rhizomes of Iris hookeriana  44-45 
             4.3. Antimicrobial activity of rhizomes of Iris hookeriana  45-
46 
             4.4. Antitumor activity of leaves of Iris hookeriana       46-47 
             4.5. Antioxidant activity of leaves of Iris hookeriana       47-49 
             4.6. Antimicrobial activity of leaves of Iris hookeriana 49 
 
 
 
 
Chapter 5: Experimental      50-56 
   
Chapter 6: Isolation & characterisation of Ih/DC and Ih/DC2 57-58
            
         6.1. SAR studies of Ih/DC vis-à-vis antitumor activity 58-60 
 Summary                                                                                     61-63 
Appendices                                                                                    64-69 
      
   Appendix I :  List of Symbols/Abbreviations  64-65 
Appendix II :  List of figures    66 
Appendix III :  List of Tables    67 
Appendix IV :  Phytochemical tests    68 
Appendix V :  Spray Reagents    69 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1 
Introduction 
 
 
 
 
 
 
 
1.1.NATURAL PRODUCTS AND DRUG DISCOVERY 
Nature has always been a valuable source of drugs and continues to deliver lead 
compounds despite the unprecedented opportunities afforded by the medicinal 
chemistry. In the form of its vast repository (phyto-diversity), nature has provided a 
complete store house of remedies to cure most of the ailments of mankind. It is 
estimated that less than 10% of this world‟s biodiversity has been studied seriously as 
source of medicines
1
. Yet, from this small fraction, humanity has reaped enormous 
benefits in the form of bioactive natural products that span all the way from small 
molecules such as the toxin responsible for Dogger Bank itch
2
 to complex, polycyclic 
compounds such as paclitaxel. 
We are grateful to the plant kingdom for such useful drugs like vinblastine and 
vincristine from the African periwinkle, Caratharanthus roseus used for the treatment 
of pediatric leukemia and Hodgkin‟s disease3. Despite competition from other drug 
discovery methods, Natural Products (NPs) are still providing their fair share of new 
clinical candidates and drugs especially in the anticancer and antihypertensive 
therapeutic areas
4
. 
NP-derived drugs are well represented in the top 35 worldwide selling ethical drug 
sales of 2004, 2005 and 2006
5
. 
 
                                                          
1  Verporte R. 1998 Drug Discovery Today, 3:232. 
2
  Charle JS Christophersen C. 1980 J. Am. Chem. Soc., 102:5108. 
3
  Balick MJ, Cox PA. 1996 In Plants, people and Culture: The Science of Botany. Scientific American Library:     New 
York, p-25. 
4
  Newman DJ, Cragg GM, Snader KM. 2003 J. Nat. Prod., 66:1022. 
5 Newman DJ, Cragg GM, Snader KM. 2004 J. Nat. Prod., 67:1216. 
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In addition to the historical success in drug discovery, natural products are likely to 
continue to be source of new commercial viable drug leads. The chemical novelty 
associated with natural products is higher than that of any other source. Additionally, 
natural products that are biologically active in assays are generally small molecules 
with drug like properties. That is, they are capable of being absorbed and metabolized 
by the body. Finally it should not remain unmentioned that the „Natural‟ aspect or 
origin of pharmaceuticals often leads to an enhanced consumer acceptance. A 
remarkable galaxy of pure compounds with different pharmacological activities has 
been isolated from natural sources.
6,7,8
 This collection has also proved to be at once-
teasing and mind expanding in its power to provoke the imagination of organic and 
medicinal chemist. A sampling of some of these natural products including 
compounds of historic interest and some of particularly novel structures is displayed 
in figure 1.1. 
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Fig.1.1. Structures of some representative natural product drugs. 
 
                                                          
6
 Butler MS. J. Nat. Prod. 2004 67:2141. J. Nat. Prod., 67:2141. 
7
 Wilson RM, Danishefsky SJ. J. 2006 Org. Chem., 71:8329. 
8 Newman DJ, Cragg GM, Snader KM. 1997 J. Nat. Prod., 60:52. 
 
 
 
1.2. FOLKLORE APPROACH TO PHARMACUETICAL DRUG DISCOVERY 
Historically, ethno pharmacology was the origin of all medicines and plant products 
were the most important sources of drugs. Use of plants in the traditional systems of 
medicine dating back to empires of Mesopotamia, Egypt, Greece, Rome, China, India 
and many other cultures
9
 has been extensively documented. This knowledge of drugs 
has accumulated over thousands of years as a result of mans inquisitive nature, so that 
today we possess many effective means of ensuring health care. In pre-industrialized 
society and in Agrarian society, plant-derived natural products were used by 
indigenous population as therapies for many diseases ranging from infections to 
emphysema. On numerous occasions, the folklore records of many different cultures 
have provided leads to plants with useful medicinal properties.
10 , 11
 Clinical, 
pharmacological and chemical studies of these traditional medicines, which were 
derived pre dominantly from plants were the basis of most early medicine such as 
aspirin, morphine, quinine, pilocarpine and digitoxin. 
Aspirin is a powerful synthetic drug that is used to treat a wide variety of ailments 
mostly as an anti-inflammatory drug and pain reliever. The natural product that 
provides the basis for aspirin is salicylic acid, which is isolated from the bark of the 
willow tree.
12
 Use of the willow tree for medicinal purposes dates back nearly 2500 
years to the time of the ancient Mediterranean empires.
13 
One of the side effects of salicylic acid is gastric discomfort and irritation, so the 
acetyl derivative of salicylic acid (acetyl salicylic acid or aspirin) is used clinically to 
partially reduce the side effects.
13
 Aspirin also functions as an important preventative 
treatment against heart disease because of its inhibition of prostaglandins, which 
affect the clotting of blood.
14
 
Codeine and morphine are two other well known and often prescribed analgesics. 
Both of these similarly structured alcholoides come from unripened seed pods of the 
opium poppy plant. Use of morphine as a drug dates back many centuries to a time 
                                                          
9
 Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z. 1985 In Medicinal Plants in Therapy. Bull. WHO, 
63:965 
10
 Swain T. 1972 In Plantsin the Development of Modern Medicine. Havard University Press: Cambridge, Ma. 
11
 Balandrin MF, Klocke JA, Wurtele ES, Bollinger WH. 1985 Science, 228:1154. 
12
 Swerdlow JL. 2000 Nature’s Medicine: Plants that Heal. National Geographic Society: Washington, D.C. 
13
Grabley S, Thiericke R. 1999. The impact of natural products on drug discovery. In Drug Discovery from 
Nature;Grabley S, Thiericke R, Eds. Springer: Berlin/Heidelberg. 
14 Dewick PM. 1997 Medicinal Natural Products: A Biosynthetic Approach. John Wiley & Sons Ltd.: Chichester. 
 
 
 
when monks saw an anesthetic and pain relieving properties of Papaver somniferum. 
While codeine is not nearly as affective in its pain relieving abilities as morphine, it 
also can be used as cough suppressant and it is a considerably less addictive drug, 
producing fewer affects of euphoria as compared to narcotic cousin.
14
Inspite of side 
effects and the possibility of addiction, morphine remains one of the most powerful 
and effective medicines for intense pain in clinical situations, an advantage that 
cannot be matched by any human made compound.
15
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Fig. 1.2. Structures of some representative traditional drugs derived from plants. 
 
 
 
 
                                                          
15
 Harry L, Brielmann 1999  J. Phytochemicals: The Chemical Components of Plants. CRC Press: Boca Raton, FL. 
 
 
 
 
 
 
 
 
 
 
 
Ethnopharmacological approach for obtaining active principles from 
medicinal plants 
It is often claimed that using similar ethno pharmacological information will greatly 
increase the chance of discovering novel chemical entities having biological activities 
that may be useful in the quest for finding drugs with greater efficacy and specificity 
for the treatment of many human diseases. The approach adopted for such a purpose 
is shown in scheme 1.1. 
 
 
 
 
 
  Established toxicity 
 No further investigation 
                                                                                         Low or no toxicity                                                                           
  
No pharmacological effects 
 No further investigation  
 
                                                                   One or more pharmacological effects                                                                                                                                                                                                          
                                                                                            established 
 
 
 
 
 
1. Field work 
Ethnopharmacology 
2. Plant used in traditional medicine 
3. Preparation of crude extracts and toxicity 
of extracts 
4. Pharmacological screening of crude extracts 
special in vitro and in vivo tests 
5. Fractionation of crude extracts 
6. Fractions subjected to pharmacological 
screening found in step-4  
7. Purification of active fractions 
 
 
 
 
 
 
 
 
 
 
 
1.3. CURRENT STATUS OF NATURAL PRODUCT RESEARCH 
Given that NPs have historically provided many novel drug leads, one would assume 
that NPs would still play a pivotal role in the drug discovery strategy of Big Pharma. 
However, most Big Pharma companies have terminated or significantly scaled down 
screening natural resource collections because they are not thought to fit into modern 
High Throughput Screening (HTS) strategies and with the expectation of reaping rich 
dividends in terms of a multiplicity of novel drugs by screening compounds produced 
Combinatorial Libraries. The impending structure of the human genome and the 
promise of a plethora of new targets added to the excitement of the time. The basic 
premise was the combinatorial chemistry would generate libraries consisting of 
millions of compounds, which would be screened by HTS and produce drug leads by 
sheer weight of numbers. The leads would be delivered in quicker time and in greater 
numbers for all therapeutic areas compared to traditional drug discovery methods, and 
as a consequence, it was not surprising tha NP research was often assigned a lower 
priority. The expected surge in productivity, however, has not materialized. Despite 
this puzzling (and seemingly disastrous) decision to significantly downplay the role of 
NPs in medicinal research in favour of far less validated discovery platform, a 
disproportionate number of new chemical entities approved even over past 10 years 
have in fact been natural products or natural product-based.
16
 The impact of natural 
products on drug development can be felt across virtually every major therapeutic 
area. Moreover, NP derived drugs are well presented in the top 35 world wide selling 
ethical drug scales of 2000 to 2007. A total of 3116 new drugs having natural origin 
were launched from January 2000 to March 2007. These include new drug types such 
as antimalarials, antibiotics, anticancer drugs and other therapeutic areas where lead 
compounds from synthetic libraries are lacking while as natural products have proven 
their worth.  
                                                          
16
 Newman DJ, Cragg GM. 2007 J. Nat. Prod., 70:461. 
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Fig.1.3. Some representative drugs derived from natural products. 
 
1.4. FLAVONOIDS- AN OVERVIEW 
Flavonoids belong to a group of natural substances with variable phenolic structures 
and are found in fruits, vegetables, grains, bark, roots, stems, flowers, tea, and wine
17
. 
These natural products were known for their beneficial effects on health long before 
flavonoids were isolated as the effective compounds. More than 4000 varieties of 
flavonoids have been identified, many of which are responsible for the attractive 
colors of flowers, fruit, and leaves
18
. Research on flavonoids received an added 
impulse with the discovery of the French paradox, i.e. the low cardiovascular 
mortality rate observed in Mediterranean populations in association with red wine 
consumption and a high saturated fat intake.  
 
                                                          
17
 Middleton EJ 1998 Effect of plant flavonoids on immune and inflammatory cell function. AdvExp Med Biology 
439:175-182. 
18
 de Groot, H., Reun U 1998 Tissue injury by reactive oxygen species and the protective effects of flavonoids. 
FundamClin Pharmacology 12: 249-255. 
 
 
 
 
The flavonoids in red wine are responsible, at least in part, for this effect
19
. 
Furthermore, epidemiologic studies suggest a protective role of dietary flavonoids 
against coronary heart disease
18
. The association between flavonoid intake and the 
long term effects on mortality was studied subsequently
20
 and it was suggested that 
flavonoid intake is inversely correlated with mortality due to coronary heart disease
21
. 
Until 50 years ago, information on the working mechanisms of flavonoids was scarce. 
However, it has been widely known for centuries that derivatives of plant origin 
possess a broad spectrum of biological activity
22
. In 1930 a new substance was 
isolated from oranges, which is believed to be a member of a new class of vitamins, 
and was designated as vitamin P. When it became clear that this substance was a 
flavonoid (rutin), a flurry of research began in an attempt to isolate the various 
individual flavonoids and to study the mechanism by which flavonoids act. 
The flavones characterized by a planar structure because of a double bond in the 
central aromatic ring of flavonoids. One of the best described flavonoids, quercetin, is 
a member of this group. Quercetin is found in abundance in onions, apples, broccoli, 
and berries. The second group is the flavanones, which are mainly found in citrus 
fruit. An example of a flavonoid of this group is narigin.  
Flavonoids belonging to the catechins are mainly found in green and black tea and in 
red wine
23
, whereas anthocyanins are found in strawberries and other berries, grapes, 
wine, and tea. An important effect of flavonoids is the scavenging of oxygen-derived 
                                                          
 
19
 Formica J V Regelson W 1995Review of the biology of Quercitin and related biflavonoids. Food Chem 
Toxicology. 33:1061-1080. 
20
 Hertog M G Kromhout D Aravanis C 1995 Flavonoid intake and long-term risk of coronary heart disease and 
cancer in the seven countries study. Arch Intern Medicine. 155:381-386. 
21
 Knekt P JarveninRuenanen A Mateela J 1996 Flavonoid intake and mortality rate in finland:A cohort study. BMJ 
312: 478-481. 
22
 Robak J Gryglewisky R J 1996 Bioactivity of flavonoidsPol J Pharmacol. 48: 555-54. 
23
 Hollman, P.C., Katan, M.B. 1999. Dietary flavonoids: intake, health effects and bioavailability. Food 
ChemToxicol. 37: 937–942. 
 
 
 
free radicals. In vitro experimental systems also showed that flavonoids possess anti-
inflammatory, antiallergic, antiviral, and anticarcinogenic properties
24
. 
 
Flavonoids can be divided into various classes on the basis of their molecular 
structure
25
. The molecular structure of each group of flavonoids is given under: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                          
24
 Hollman, P.C., van Trijp, J.M., Mengelers, M.J., de Vries, J.H., Katan, M.B. 1997. Bioavailability of the dietary 
antioxidant flavonol quercetin in man. Cancer Lett. 114: 139–140.  
25Piskula, M.K., Terao, J. 1998. Accumulation of (-)-epicatechin metabolites in rat plasma after oral administration 
and distribution of conjugation enzymes in rat tissues. J Nutr. 128: 1172–1178. 
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Intake: The average daily flavonoid intake is estimated to be 23 mg/d
26
. Intake of 
flavonoids exceed those of vitamin E and β-carotene, whereas the average intake of 
vitamin C is 3 times higher than the intake of flavonoids. Flavonoid intake seems to 
vary greatly between countries; the lowest intakes (2.6 mg/d) are in Finland and the 
highest intakes (68.2 mg/d) are in Japan (Friesenecker, 1994). Quercetin is the most 
important contributor to the estimated intake of flavonoids, mainly from the 
consumption of apples and onions
27
. A major problem in cohort studies of flavonoid 
intakes is that only a limited number of flavonoids can be measured in biological 
samples, and more importantly, only a relatively small number of fruit and vegetables 
are used to make an accurate estimation.  
Absorption: Data on the absorption, metabolism and excretion of flavonoids in 
humans are contradictory and scarce
28,29,30,31,32
. Naturally occurring flavones exist 
predominantly in a glycosylated form rather than in their aglycone form. The form of 
the flavonoid seems to influence the rate of absorption. Hollman and Katan
32
 
suggested that the glycosylated forms of quercetin are absorbed more readily than are 
the aglycone forms; however, this has been questioned by other researchers
33
. Some 
studies showed that the most intensely studied dietary flavonoid, quercetin, is 
absorbed in significant amounts
34
. The role of flavonoid glycosylation in facilitating 
                                                          
26 Haenen, G.R., Bast, A. 1999. Nitric oxide radical scavenging of flavonoids. Methods Enzymol. 301: 490–503. 
27
 Knekt, P., Jarvinen, R., Seppanen, R. 1997. Dietary flavonoids and the risk of lung cancer and other malignant 
neoplasms. Am J Epidemiol. 146: 223–230.  
28
 Hollman, P.C., van Trijp, J.M., Buysman, M.N. 1997. Relative bioavailability of the antioxidant flavonoid 
quercetin from various foods in man. FEBS Lett. 418: 152–156.  
29
 Hollman, P.C., Gaag, M., Mengelers, M.J., van Trijp, J.M., de Vries, J.H., Katan, M.B. 1996. Absorption and 
disposition kinetics of the dietary antioxidant quercetin in man. Free RadicBiol Med. 21: 703–707.  
30
 Hollman, P.C., Katan, M.B. 1997. Absorption, metabolism and health effects of dietary flavonoids in man. 
Biomed Pharmacother. 51: 305–310.  
31
 Hollman, P.C., van Trijp, J.M., Mengelers, M.J., de Vries, J.H., Katan, M.B. 1997. Bioavailability of the dietary 
antioxidant flavonolquercetin in man. Cancer Lett. 114: 139–140.  
32 Hollman, P.C., Katan, M.B. 1999. Dietary flavonoids: intake, health effects and bioavailability. Food 
ChemToxicol. 37: 937–942. 
33
 Manach, C., Morand, C., Demigne, C., Texier, O., Regerat, F., Remesy, C. 1997. Bioavailability of rutin and 
quercetin in rats. FEBS Lett. 409: 12–16.  
34
 Young, J.F., Nielsen, S.E., Haraldsdottir, J. 1999. Effect of fruit juice intake on urinary quercetin excretion and 
biomarkers of antioxidative status. Am J ClinNutr. 69: 87–94.  
 
 
 
absorption is questioned by the fact that catechin, which is not glycosylated in nature, 
is absorbed relatively efficiently
35
.  
Conjugation: It is generally accepted that the conjugation pathway for flavonoids 
(catechins) begins with the conjugation of a glucuronide moiety in intestinal cells. 
The flavonoid is then bound to albumin and transported to the liver
36,37
. The liver can 
extend the conjugation of the flavonoid by adding a sulfate group, a methyl group, or 
both. The addition of these groups increases the circulatory elimination time and 
probably also decreases toxicity. There are several possible locations for the 
conjugates on the flavonoid skeleton. The type of conjugate and its location on the 
flavonoid skeleton probably determine the enzyme-inhibiting capacity, the antioxidant 
activity, or both of the flavonoid. Recent data suggest that the regular intake of 
flavonoids results in a more predominant formation of several conjugates, which 
probably results in greater activity. A detailed example is given in the study by 
Manach et al
35
, in which a high dose of quercetin was administered to a group of rats 
adjusted to flavonoid intake and to a non-adjusted group. Results of this study 
indicated that the conjugated compound isorhamnetin was formed in higher quantities 
in the adjusted group, which is important because it is known to be even more active 
than is the aglycone form of quercetin on xanthine oxidase inhibition
35
. 
Concentrations of individual flavonoids and their biologically active conjugates may 
not be high enough after occasional intake to explain the low mortality rates from 
cardiovascular disease in Mediterranean countries. However, because the half-lives of 
conjugated flavonoids are rather long (23–28 h)34, accumulation may occur with 
regular intakes, which may in turn result in sufficiently active flavonoid 
concentrations.  
Toxicity: Formica and Regelson
38
 gave an interesting overview of the in vitro and in 
vivo studies on quercetin. The early data on toxic side effects are mainly derived from 
                                                          
35
 Okushio, K., Matsumoto, N., Kohri, T., Suzuki, M., Nanjo, F., Hara, Y. 1996.  Absorption of tea catechins into rat 
portal vein. Biol Pharm Bull.19: 326–329.  
36
 Manach, C., Morand, C., Texier, O. 1995. Quercetin metabolites in plasma of rats fed diets containing rutin or 
quercetin. J Nutr. 125: 1911–1922.  
37
 Piskula, M.K., Terao, J. 1998. Accumulation of (-)-epicatechin metabolites in rat plasma after oral 
administration and distribution of conjugation enzymes in rat tissues. J Nutr. 128: 1172–1178.  
38
 Formica, J.V., Regelson, W. 1995. Review of the biology of quercetin and related bioflavonoids. Food Chem 
Toxicology. 33: 1061–1080.  
 
 
 
in vitro studies. At a conference of the Federation of American Societies for 
Experimental Biology in 1984 on mutagenic food flavonoids, carcinogenicity was 
reported in just 1 of 17 feeding studies conducted in laboratory animals
39,40
. Dunnick 
and Hailey
41 
reported that high doses of quercetin over several years might result in 
the formation of tumors in mice. However, in other long-term studies, no 
carcinogenicity was found
42
. In contrast with the potential mutagenic effects of 
flavonoids in earlier studies, several more recent reports indicate that flavonoids, 
including quercetin, seem to be antimutagenic in vivo 
43,44
. A large clinical study by 
Knektet al
45
, in which 9959 men and women were followed for 24 years, showed an 
inverse relation between the intake of flavonoids (eg, quercetin) and lung cancer. One 
possible explanation for these conflicting data is that flavonoids are toxic to cancer 
cells or to immortalized cells, but are not toxic or are less toxic to normal cells. If this 
is true, flavonoids might play a role in the prevention of cancer that is worthy for 
further investigation.  
Clinical Effects: An overview of the hypothetical links between the working 
mechanisms and clinical effects of flavonoids is given in Figure 2.  
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Fig1.4.Hypothesis of the links between the working mechanisms of flavonoids 
and their effects on disease. 
Antioxidative effects: The flavones and catechins seem to be the most powerful 
flavonoids for protecting the body against reactive oxygen species. Body cells and 
tissues are continuously threatened by the damage caused by free radicals and reactive 
oxygen species, which are produced during normal oxygen metabolism or are induced 
by exogenous damage
46 , 47
. The increased production of reactive oxygen species 
during injury results in consumption and depletion of the endogenous scavenging 
compounds. Flavonoids may have an additive effect to the endogenous scavenging 
compounds. 
Radical scavenging activity: Flavonoids can prevent injury caused by free radicals in 
various ways. One way is the direct scavenging of free radicals. Flavonoids are 
oxidized by radicals, resulting in a more stable, less-reactive radical. In other words, 
flavonoids stabilize the reactive oxygen species by reacting with the reactive 
compound of the radical. Selected flavonoids can directly scavenge superoxides, 
whereas other flavonoids can scavenge the highly reactive oxygen derived radical 
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called peroxynitrite. Epicatechin and rutin are also powerful radical scavengers
48
. The 
scavenging ability of rutin may be due to its inhibitory activity on the enzyme 
xanthine oxidase. By scavenging radicals, flavonoids can inhibit LDL oxidation in 
vitro
49
. This action protects the LDL particles and, theoretically, flavonoids may have 
preventive action against atherosclerosis.  
Anti-inflammatory effects: Cyclooxygenase and lipoxygenase play an important role 
as inflammatory mediators. They are involved in the release of arachidonic acid, 
which is a starting point for a general inflammatory response. The exact mechanism 
by which flavonoids inhibit these enzymes is not clear. Quercetin, in particular, 
inhibits both cyclooxygenase and lipoxygenase activities, thus diminishing the 
formation of these inflammatory metabolites
50
.  
Antitumour effects: Antioxidant systems are frequently inadequate, and damage 
from reactive oxygen species is proposed to be involved in carcinogenesis
51 , 52
. 
Reactive oxygen species can damage DNA, and division of cells with unrepaired or 
misrepaired damage leads to mutations.  
It has been stated that flavonoids, as antioxidants, can inhibit carcinogenesis
53
. Some 
flavonoids- such as fisetin, apigenin, and luteolin are stated to be potent inhibitors of 
cell proliferation
54
. Furthermore, it has been speculated that flavonoids can inhibit 
angiogenesis
55
. Angiogenesis is normally a strictly controlled process in the human 
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body. The process of angiogenesis is regulated by a variety of endogenous angiogenic 
and angiostatic factors. It is switched on, for example, during wound healing. 
Pathologic, unregulated angiogenesis occurs in cancer
56
. Angiogenesis inhibitors can 
interfere with various steps in angiogenesis, such as the proliferation and migration of 
endothelial cells and lumen formation. Among the known angiogenesis inhibitors, 
flavonoids seem to play an important role
57
.  
Antithrombogenic effects: Platelet aggregation contributes to both the development 
of atherosclerosis and acute platelet thrombus formation, followed by embolization of 
stenosed arteries. Selected flavonoids, such as quercetin, kaempferol, and myricetin 
were shown to be effective inhibitors of platelet aggregation in dogs and monkeys
58
.  
Antiviral effects: The antiviral activity of flavonoids was shown in a study by Wang 
et al
59
. Some of the viruses reported to be affected by flavonoids are herpes simplex 
virus, respiratory syncytial virus, parainfluenza virus, and adenovirus. Quercetin was 
reported to exhibit both antiinfective and antireplicative abilities. The interaction of 
flavonoids with the different stages in the replication cycle of viruses was previously  
 
described
60
. For example, some flavonoids work on the intracellular replication of 
viruses, whereas others inhibit the infectious properties of the viruses. 
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Table1.  Enzyme modulator activity of flavonoids 
S.No. ENZYME FLAVONOID MECHANISM 
1. Protein kinase Quercitin Inhibited the phosphorylated 
activity of the rous sarcoma 
virus-transforming gene. 
2. Phospholipase A 
2 (pla2) 
Phospholipase C 
Kaempferol Inhibition of phossphorylase 
kinase and also of protein 
tyrosine kinase. 
3. ATPases Kaempferol Catalyzes the Myosin light 
chain kinase (MLICK) 
4. Lipoxygenases 
and 
Cyclooxygenases 
Quercetin.Kaempferol-
3-O -glycoside  
Inhibition of PLA3 from 
human & rabbit leukocytes. 
  
 
scutellarein Blocking the PLC activation & 
formation of inositol 
trisphosphate (IP3) & 
diacylglycerol (DGA).Mg21–
ectolATPase of human 
leukocytes. 
  Genistein  Quercetin Increase in ATPase activity by 
conformational changes in the 
structure of myosin. 
  Quercetin Effect on arachidonic acid 
metabolism via the LO and CO 
(TxB2, PGE2, 6-keto-PGFIA) 
pathways. 
1.5. GENUS IRIS 
NATURALLY OCCURRING FLAVONOIDS OF IRIS 
There have been a variety of flavonoid compounds isolatedfrom Iris during 1999-
2008. These compounds can be classified in the following six sections (isoflavones & 
their glycosides, flavones & their glycosides, flavonols & their glycosides, flavanones 
& flavanonols, peltogynoids and coumaronochromones & rotenoids), which follow a 
 
 
 
standard pattern so far as is practicable. The normal flavonoid constituents of Iris 
reported during 1999-2008 can be classified, according to their skeletons, into five 
groups: isoflavones & their glycosides, flavones & their glycosides, flavonols & their 
glycosides, flavanones and dihydroflavonols. They constitute a relatively 
homogeneous group of compounds, almost all being derivative of the basic tricyclic 
structure of isoflavone or flavones with simple patterns of O-substitution (e.g. 
hydroxy, methoxy and methylenedioxy) and glycosylation. They differ only in the 
nature of the substituent position of rings A and B. There are relatively common 5,7-
di- or 5,6,7-tri-O substitution pattern in the A-ring. Importantly, the most pronounced 
feature in this ring is 6,7-methylenedioxy substitution (32 out of 94 compounds 
possess the substitution pattern), which is less common in flavonoids obtained from 
other genus of Iridaceae. Furthermore, in the B-ring they often possess 2'- or 4'-O-
substitution, 2',3'-, 3',4'- or 4',5'-di-O-substitution and 3',4',5'-tri-O-substitution, but it 
is noteworthy that 2'-O-substitution & 2',3'-di-O-substitution are rare in the aglycones 
of their glycosides. Finally, the majority of flavonoid glycosides characterized to date 
are either 6-,7-, 3- or 4'- glycosides. There are also classes of modified flavonoids 
found in Iris species, which in formal terms can be regarded as cyclized derivatives of 
the normal flavonoids mentioned above, namely peltogynoids, coumaronochromones 
and rotenoids. Similarly with the regular flavonoids, they possess simple patterns of 
O-substitution. The common feature of the compounds is that the substituent at C-2 or 
C-3 position is alwaysfound in the form of an oxygen-bearing ring fused with rings B 
and C. 
As demonstrated previously by Iwashinaet al.
61
,isoflavones (mainly contained in the 
rhizomes) and glycosyl flavones (mainly found from the leaves and flowers of almost 
Iris species), either C-glycosyl flavones or O-glycosyl flavones, are major 
components of the genus Iris.  We further find that O-glycosyl isoflavones (mainly 
contained in the rhizomes) are also major components of Iris species. The residue 
flavones, flavonols & their glycosides, flavanones, dihydroflavonols, peltogynoids, 
coumaronochromones and rotenoids are all minor components. Importantly, 
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Choudharyet al. first isolated five new peltogynoids from Iris bungei in 2001, and that 
was the first report of peltogynoid-type compounds found in the family of Iridaceae.
62
 
1.5.1. Isoflavones and their Glycosides 
Isoflavones and their glycosides are the most important flavonoid compounds isolated 
from the genus Iris. In most reports they were found in the rhizomes, rare in the 
flowers and leaves. The number of the isoflavones and their glycosides described in 
the literature during the reporting period exceeds that of any other subclass of 
flavonoids. 
Isoflavones 
As many of the likely permutations of hydroxy, methoxy, and methylenedioxy 
substitutions have already been described, not surprisingly, the number of new 
isoflavones reported between 1999 and 2008 is relatively small. There are only five 
records (1-5) characterized. 5,7,3',4'-tetrahydroxy-6-methoxyisoflavone (irilin D, 1) 
was isolated from the underground parts of Iris bungei, a species cited as a medicinal 
plant in Mongolian, along with four new flavonols, irisflavone A-D (26-29), and three 
known isoflavones, irilins A-B and tlatancuayin
62 
irilin D (1) had been earlier reported 
as a synthetic product
63
, and that was the first time it was characterized as a new 
natural product. The whole plant of Iris tenuifolia yielded 5,2',3'- trihydroxy-6,7-
methylenedioxyisoflavone (tenuifone, 2)
64
, which possesses the uncommon 6,7-
methylenedioxy substitution in the A-ring. 
 
 
 
Another example with this substitution is 5,3'-dihydroxy-4'-methoxy-6,7-
methylenedioxyisoflavone (Soforanarin A, 3) from methanolic extracts of the 
rhizomes of Iris soforana of Turkish origin, which also yielded 6,3',4'- trihydroxy-
5,7,5'-trimethoxyisoflavone (Soforanarin B, 4) and other six known isoflavones
65
. To 
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the best of our understanding, it was the first phytochemical work conducted on this 
species. Compounds (1-4) are examples exhibiting relatively common 5,6,7-tri-O-
substitution pattern of the A- ring, but 7, 8, 5'-trihydroxy-6, 3', 4'-
trimethoxyisoflavone (5) obtained from the underground parts of Iris potaninii
66
 is 
unusual to some extent, which possesses 8-hydroxy substitution in the A-ring. This 
substitution is relatively uncommon in isoflavones
67
. 
 
 
Fig.1.5.Structures of new isoflavones (1-5) isolated from Iris 
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Fig.1.6. Structures of new flavones (25-29) isolated from Iris. 
Isoflavone Glycosides 
Most of the saccharides found in isoflavone glycosides reported between 1999 and 
2008 are monosaccharides or disaccharides. The monosaccharides are normally D-
glucopyranosides 
( D-Glcp), and similarly, the disaccharides are mainly D-Glcp-(1,6)- D-Glcp. They 
usually form O-glycosides, with the sugar moiety often linked to C-7or C-4' position 
of the known aglycones. Among the new isoflavone glycosides isolated from the 
genus Iris during the reporting period, there are five containing monosaccharides, 
nine containing disaccharides and one containing trisaccharide. In the following part 
they are elucidated in detail. Compounds (6) (Iris Carthaliniae)
68
, (7) and (8) (Iris 
germanica)
69
 are relatively common 7-O- ， 4'-O- D-glucopyranosyl isoflavones 
obtained from Iris species.  
Two unusual isoflavone monosaccharides are iris leptophyllidin(9) from rhizomes of 
Iris leptophylla and 8,3',5'-trihydroxy-7,4'-dimethoxy-6-O-D-glucopyranosyl 
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isoflavone (10) from underground parts of Iris potaninii
66
, which are 3'-O- and 6-O- 
D-glucopyranosyl isoflavone, respectively. 
Similarly with 7, 8, 5'-trihydroxy-6, 3', 4'-trimethoxyisoflavone (5), the aglycone of 
compound (10) also possesses the uncommon 8-hydroxy substitution in the A-ring. 
Compounds (11), (15), (17) (Iris germanica)
71
, (13) (Iris pseudopumila)
72
, (12), (16) 
(Iris carthaliniae)
68
contain relatively common 7-O-, 4'-O -D-Glcp-(1,6)-D -Glcp.The 
uncommon disaccharide L-Rhap-(1,2)-D-Glcp was reported in a 4'-O-glycoside of 
irilone, irilone-bioside (14) obtained from rhizomes of Iris leptophylla together with 
iris leptophyllidin (9)
70
. 
 
Fig.1.7. Structures of new monosaccharides (6-10) isolated from Iris 
Compounds (11-17) are all linear disaccharides, but (18) (Iris spuria)
73
 and (19) (Iris 
germanica)
71
 are uncommon examples of two monosaccharides bound to different 
positions of the aglycones, respectively. (13) (Iris pseudopumila)
72
, contain relatively 
common 7-O-, 4'-O-D-Glcp-(1,6)-D -Glcp. (18) (Iris spuria), a monosaccharide is 
bound to different positions of the aglycones.
73
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The more noteworthy one is germanasim G (19), which is a 3',4'-di-O- D-
glucopyranosyl isoflavone with 2-methoxy-4-acetylphenyl group bound to the C-2 
position ofthe 4'-glucopyranoside. The acylated phenyl derivative of a glucose moiety 
is very rare among the isoflavone glycosidesobtained from the genus Iris. The unique 
example of new isoflavone glycoside containing a linear trisaccharide is germanasim 
F(20) isolated from rhizomes of Iris germanica, together with germanasim C-E and G 
(11, 15, 17, 19).
71
 The linear trisaccharide of germanasimF(20), -D-Glcp-(1 2)- L-
Rhap-(1,6)-DGlcp, is characterized in a 4'-O-glycoside of nigricin (irisolone). 
 
 
Fig.1.8.Structures of isoflavone disaccharides and trisachharides isolated from Iris 
 
 
1.5.2. CHEMICAL AND SPECTRAL METHODS OF CHARACTERIZATION: 
Chemical methods for the structure determination of isoflavones are well documented 
(ollis,1962; Dean,1963). Flavonoids are generally soluble in water and alcohol, 
but insoluble in organic solvents; the genins are only sparingly soluble in water but 
 
 
 
are soluble in ether. Flavonoids dissolve in alkalis, giving yellow solutions which on 
the addition of acid become colorless. Isoflavones are much more susceptible to alkali 
hydrolysis than flavones. The production of a deoxybenzoin under mild conditions, 
together with formic acid, constitutes important evidence for an isoflavone structure. 
Confirmation may further be obtained by resynthesis of the isoflavone from the 
deoxybenzoin with the appropriate reagent. 
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Fig.1.9. Alkali degradation of isoflavones. 
 
 
CHEMICAL METHODS: 
1) FLUORESCENCE QUENCHING TEST 
A novel fluorescence quenching test for the detection of flavonoid degradation by 
microorganisms was developed. The test is based on the ability of the flavonoids to 
quench the fluorescence of 1,6-diphenyl-1,3,5-hexatriene (DPH). Several members of 
the anthocyanidins, flavones, isoflavones, flavonols, flavanones, dihydroflavanones, 
chalcones, dihydrochalcones and catechins were tested with regard to their quenching 
properties. The anthocyanidins were the most potent quenchers of DPH fluorescence, 
while the flavanones, dihydroflavanones and dihydrochalcones, quenched the 
fluorescence only weakly. The catechins had no visible impact on DPH fluorescence. 
The developed test allows a quick and easy differentiation between flavonoid-
degrading and flavonoid-non-degrading bacteria. The investigation of individual 
 
 
 
reactions of flavonoid trans- formation with the developed test system is also 
possible.
74
 
2) SHINODA TEST 
To dry powder or extract, add 5ml. 95% ethanol. Few drops conc. HCL and 0.5 g 
magnesium turnings. Pink color observed. To small quantity of residue, add lead 
acetate solution. Yellow colored precipitate is formed. Addition of increasing amount 
of sodium hydroxide to the residue shows yellow coloration which decolorises after 
addition of acid.
75 
SPECTRAL METHODS: 
The combination of HPLC with mass spectrometric detection, electrospray ionization 
(ESI) and atmospheric pressure chemical ionization (APCI) has proved to be a useful 
tool in analysing natural products. The combination of HPLC–APCI allows eﬃcient 
separation and identiﬁcation of isoﬂavones with greater eﬃciency than HPLC (with 
UV detection) alone. Negative-ion APCI provides quality mass spectra and by 
variation of conditions, the collision-induced dissociations which are generated 
permits structure elucidation. Further information on isoﬂavone structure can be 
obtained by addition of deuterium oxide to the sample which induces peak shifts in 
the mass spectra and helps to identify the number of exchangeable hydrogen atoms in 
each molecule. The use of capillary electrophoresis (CE) in the determination of iso- 
ﬂavones has also been described. In contrast to HPLC, the CE method is rapid, it does 
not require solvent gradient or elution and it does not consume organic solvents for 
elution. Capillary electrophoresis in combination with electrospray ionization–mass 
spectrometry (ESI–MS) has been shown to be a suitable technique for the 
determination of isoﬂavones. 
The use of CE–ESI–MS which permits the eﬃcient separation and identiﬁcation of 
isoﬂavones with higher speciﬁcity than CE (with UV detection) alone, allows both the 
determination of the molecular mass of isoﬂavones and the recognition of various 
functional groups through analysis of several diagnostic fragment ions. Two 
dimensional NMR techniques including 
1
H–1H (COSY), 13C–1H (HETCOR), 13C–1H 
(COLOC) and NOESY are now routine methods for the structure elucidation of 
isoﬂavonoids. Application of 2D NMR techniques has led to the unambiguous 1H and 
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13C NMR assignments of the isoﬂavonoids 5,7-dihydroxy-4‟-methoxyisoﬂavone 
(biochanin A), 2‟,5,7-trihydroxy-4‟-methoxyisoﬂavone and 5,7-dihydroxy- 2‟,4‟-
dimethoxyisoﬂavone, isolated from Virola caducifolia.76 
1.5.3. Spectral properties of Isoflavones: 
The isoflavones remain by far the most common of the isoflavonoids. Most of the 
isoflavones known are simple isoflavones which can be grouped into the 18 
oxygenation patterns. The remainder may be conveniently called complex 
isoflavones, since each compound contains one or more isoprenoid substituents 
usually further cyclised with a hydroxyl group. Isoflavones can be distinguished from 
flavones and isoflavanones by UV and NMR spectroscopy. The simple isoflavones 
have intense absorption at 255-275 nm and generally a less intense band or inflection 
at 310-330 nm. The low intensity of absorption of the second band of isoflavones is a 
valuable diagnostic feature. The NMR signal of the olefinic proton at C-2 in 
isoflavones appears as a characteristic down field singlet at 7.8δ (8.3δ in DMSO) as 
compared to 6.7δ for the C-3 proton in flavones. The impact of NMR on structure 
determination is most evident in the complex isoflavones; the presence and nature of 
the isoprenoid substituents in these compounds is readily revealed. 
Mass spectrometry cannot distinguish between flavones and isoflavones since 
fragmentation via the retro Diels-Alder process results in identical fragments for both 
classes of compounds. The presence of 2′-methoxyl group in isoflavones, however, 
has been found to influence the fragmentation pattern profoundly. These compounds 
show a strong M-31 peak due to loss of methoxyl; this probably occurs via ring 
closure. 
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Fig.1.10. MS fragmentation of 2′- methoxyisoflavones. 
 
1.5.4. BIOLOGICAL PROPERTIES OF ISOFLAVONES: 
A distinctive feature of the isoflavonoids is the possession of biological activity 
within the group. In contrast to other flavonoids which on the whole are innocuous 
substances (whalley, 1959), isoflavonoids have oestrogenic, insecticidal, piscicidal 
and anti-fungal properties. 
Isoflavones have a strikingly similar chemical structure to mammalian estrogens. 
Therefore, it is not surprising that isoflavones bind to estrogen receptors and affect 
estrogen-regulated gene products.
77
 Traditionally, isoflavones have been considered to 
be very weak estrogens, possessing the activity between 1 x 10
-4
 and 1 x 10
-2
 of 17ß-
estradiol on a molar basis.
78
 Even these estimates of estrogenic activity suggest 
isoflavones likely exert physiological activity in vivo, since people who consume 
soyfoods may have serum isoflavone levels up to 10,000 fold higher than endogenous 
estrogen levels.
79
 The high serum and tissue isoflavone concentrations compensate for 
their relative weakness. However, for several reasons, these older views of the relative 
estrogenicity of isoflavones may need to be revised. First, genistein binds with almost 
the same affinity to the recently discovered second estrogen receptor, estrogen 
receptor beta (ERb), as 17ß -estradiol.
80
 Until recently, estimates of the estrogenic 
activity of isoflavones were based largely on estrogen receptor alpha (ERa), for which 
genistein has much less affinity. Second, isoflavones may bind less tightly than 
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estrogen to serum proteins making them more available to the tissues.
81
 Third, 
isoflavones may be tissue-selective, exerting quite pronounced estrogenic activity in 
some tissues,
82
 but not in others.
83
 The ability to exert tissue-selective effects likely 
stems in part from the different tissue distribution of ERb and ERa.
84
 This observation 
has prompted speculation that isoflavones are natural selective estrogen receptor 
modulators (SERMs), like the drugs tamoxifen and raloxifene,
85
 and therefore might 
provide the benefits of estrogen without the disadvantages – but this is still 
speculative. Although isoflavones possess estrogenic and possibly antiestrogenic 
activity,
86
 the physiological effects of isoflavones, especially genistein, are likely only 
partially related to direct interaction with or binding to estrogen receptors. 
This is evident by the finding that genistein inhibits the growth of a wide range of 
both hormone- dependent and independent cancer cells in vitro
87
 – a result thought to 
be due to the ability of genistein to influence signal transduction.
88
 In vitro, genistein 
inhibits the activity of many enzymes and cellular factors that control the growth of 
cells.
89
 Isoflavones also possess antioxidant activity.
90
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The myriad biological effects of isoflavones accounts for their possible beneficial 
roles in diseases as diverse as osteoporosis,
91  
coronary heart disease,
82
 malaria,
92 
cystic fibrosis,
93 
and alcoholism.
94
 In clinical studies demonstrating the health benefits 
of soyfood consumption, subjects typically ingest between 40 and 150 mg of 
isoflavones per day. Some studies report average Japanese consumption may be as 
high as 50 mg/day. Obviously, a sizeable portion of the population consumes more 
than this amount. In fact, several studies reported that isoflavone intake by 
approximately five percent of the Japanese population is 100 mg/day. Therefore, a 
reasonable upper adult daily limit for isoflavone intake is considered to be about 100 
mg (aglycone units), an amount found in approximately three servings of traditional 
soyfoods. Consuming three servings of soyfoods per day is much more than most 
Americans currently consume, but still consistent with recommendations to choose a 
variety of foods. Furthermore, clinical studies conducted for as long as one year in 
which subjects have consumed more than 100 mg of isoflavones per day have not 
reported any adverse effects. 
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Chapter 2 
Review of Literature 
 
 
 
 
 
 
 
 
2. REVIEW OF LITERATURE:  
Genus Iris belonging to family Iridaceae represents one such genera which has a 
worldwide distribution comprising 1630-1750 species classified into 77
95
 genera. 
India is represented by 34 species and 5 varieties under 14 genera of Iridaceae
96
. 
Kashmir is represented by 12 species
97
. Out of these species, two less explored 
species have been selected for the studies.  
Iris species have an immense medicinal importance. Iris species are used in treatment 
of biliousness with liver dysfunction
98
, cancer, inflammations in addition to bacterial 
and viral infections
99
.They are used as antispasmodic
100
, emetic, laxative
101
, antidote 
and haemostatic agents
102
. Furthermore, they exhibit molluscicidal activity
103
 and 
significant anthehminitic activity
104
. The compounds isolated from these species are 
reported to have anti tumor
105
, piscicidal, antioxidant, antituberculousis, anti-
inflammatory
106
, antiplasmodial and antifungal
107
 properties. 
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In addition to these properties, Iris have the property of skin lightening and showing 
estrogenic activities. Also roots and leaves of Iris are given in fever
108
. They find their 
use as aperients
109
, diuretic
110
and in the treatment of bruise, back pain and diarrhea
111
 
as well. Iris nepalensis rhizomes are used in Indian Indigenous System of Medicines 
under the name of “Sosan” for a variety of heart diseases112. 
The major groups of compounds that are present in the Iris are flavonoids and 
titerpenoids. Other components present are anthocyanins, flavonols, flavones, 
isoflavones, flavonones, xanthones and quinones. 
Table 2. Phytoconstituents of various species of Iris. 
 
S. No. Species Compounds reported References 
1 I. lactea 
(LEAVES) 
C-glycosylflavones 
IrislactinA and IrislactinB 
W. J. Shen, M. J. Qin, P. Shu and 
C. F. Zhang (2008). Chinese 
chemical letters, 19 (821-824). 
2 I. ensata 5-hydroxy-4′-methoxyflavone, 
5-hydroxy-3′-methoxyflavone, 
5-hydroxy-2′-methoxyflavone. 
new type ofmajor 
anthocyanins 
medium chain fatty acids 
 
E.V. Boltenkov, V.G. Rybin, and 
E.V. Zarembo (2005).  Chemistry 
of Natural Compounds, 41 (5). 
 
J. B. Kim,  J. B. Kim, K. H. Kim, 
S. K. Hwang, Y. H. Kim, K. J. 
Cho, Y. S.Hwyang, R.D. Park. 
(2001). Hanguk Nonghwa 
Hakhocchi.44(1), 20-23. 
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3 I. germanica Triterpenoids G.T. Verlag .(2001). Plant Med. 
67(1),79-81. 
 
 
 
4 I. petrana xanthose and isoflavones T . Aburjai., B. Amro, S. Al-
Khalil, D.Al-eisawi. (2000). Acta 
Technol. Legis Med. 11(3), 137-
145. 
5 I. germanica L. 
var. alba 
(RHIZOMES) 
isoflavonoid glycoside, 8,4′-
dimethoxyisoflavone-7-O-
glucoside together with 
irisflorentin, irisolone, 
irisolone-4′-diglucoside, 
iristectorin A and irisxanthone 
A.A. Ali, N.A. El-emary, F.M. 
Darwish. (1993) Bull. Pharm. Sci., 
16(2), 159-62. 
6 I. germanica 
L.var.alba 
(LEAVES) 
flavone-C-glycoside, 
swertisin, xanthone glycoside 
mangiferin and isomangiferin 
A.A. Ali, N.A. El-emary, F.M. 
Darwish. (1993) Bull. Pharm. Sci., 
16(2), 159-62. 
7 I. pseudacorus 
L. 
two isoflavones- irisolidone 
and irigenin with an 
isoflavone glycoside iridin 
A.A. Ali, N.A.  El-emary, F.M. 
Darwish(1993) Bull. Pharm. Sci., 
16(2), 159-62. 
8 I. tectorum iristectorenes A and C-G, 
monocyclic triterpene esters 
S. Katsura, T. Toshiya, H. Kazuo, 
K.Ryohei. (1994), Phytochemistry. 
36 (2), 425-431. 
9 I. ensata 
(FLOWERS) 
p-coumaroyl glycosides of 
cyanidin and peonidin 
T. Yabuya, M. Nakamura, A. 
Yamasaki. (1993). Euphytica. 
74(1-2), 47-50. 
 
 
 
10 I. pseudacorus 
(LEAVES) 
5,7,3′-trihydroxy-4′-
methoxycoumaronochromone
(ayameninE), two flavones 
(apigenin and hispidulin), two 
flavanonols (alpinone and 7-
O-methyldihydrokaempferol) 
and 5,7,2′-
trihydroxyflavanone. 
H. Fujinori, T. Satoshi, M. Junya. 
(1991). Phytochemistry. 30(7), 
2197-2198. 
 
11 I. ensata C-glycosides of luteolin N.I . Pryakhina, K.F. Blinova. 
(1984). Khim. Prir. Soedin. 1, 
109-110 
12 I. germanica three isoflavonoids 
irisolidone, irigenin, iridin 
A.A. Ali, N.A.  El-Emary, M.A. 
El-Moghazi,F.M.  Darwish, A.W.  
Frahm. (1983). Phytochemistry. 
22(9), 2061-2063. 
13 I. versicolor L 
(RHIZOMES) 
monocyclic  C 31- 
triterpenoid 
K. Wolfgang, M. F. Josef,  
J.Lothar, Z. C. Naturforsch. 
(1983). Biosci. 38c (9-10), 689-92. 
14 I. kumaonensis isoflavone iriskumaonin A.K. Kalla, M.K. Bhan,K.L. Dhar. 
(1978). Phytochemistry, 17(8), 
1441-2. 
15 I. ensata 
(AERIAL 
PARTS) 
4′-7-dimethoxyapigenin-6-C-
β-D-glucopyranosyl-O-L-
rhamnose. 
K.F. Blinova, V.I. Glyzin, N.I. 
Pryakhina. (1977). Khim. Prir. 
Soedin., (1), 116. 
16 I. hollandica 
(BULBS) 
3-demethylplastoquinone 9 
and  
3-demethylplastoquinone 8 
E.G. Claudine, T. Claude, P. 
Judith. (1977). Nouv. J. Chim 
1(4), 323-325. 
17 I. kashmiriana Irisolidone K.L. Dhar, A.K. Kalla. (1975). J. 
Indian Chem. Soc. 52(8), 784. 
18 I. pseudacorus Irisquinone S. katsura, K. Ryohei.(1975) 
Chem, Ind., (8), 349-50. 
19 I. germanica Carotenoids B. Richard,  L.J. Synnove (1975) 
Phytochemistry, 14 (3), 851-2. 
 
 
 
20 I. hollandica Terpenes L.S. George, A.A. De hertogh, 
A. Amedo. (1972) J. Amer. Soc. 
Hort. Sci., 97(2), 189-91. 
21 I. tectorum isoflavone glycoside M.  Naokata, S. Masami, S. Mineo, 
A. Munehisa. (1972) Chem. 
Pharm. Bull., 20(4), 730-3. 
22 I. hollandica Steroids L.S. George, A.A. De hertogh,  A. 
Amedo.(1972) J. Amer. Soc. Hort. 
Sci.,7(4), 411-12. 
23 I. kumaonensis Isoflavones  K.L. Dhar, A.K. Kalla. (1972) 
Phytochemistry, 111(10), 3097-8 
24 I. tingitana delphanin and C-glycosyl 
flavones 
A. Sam, N.R. Stewart, K.H. Norris, 
D.R.  Massie. (1970) 
Phytochemistry, 9(3), 619-27. 
25 I. germanica flavone C-glycosides A. Kawase, K. Yagishita. (1968). 
Agr. Biol. Chem. 32(4), 537-538. 
26 I.ensata 
(garden iris) 
mangiferin and 
glycophenolics 
E.C. Bate-Smitha, J.B. Harborne. 
(1963) Nature 198, 1307-1308. 
 
 
2.1. OBJECTIVES FOR UNDERTAKING STUDIES OF IRIS 
ENSATA AND IRIS HOOKERIANA: 
Flavonoids are ubiquitous in plant foods and drinks and therefore, a significant 
quantity is consumed in our daily diet. These are variously associated with the sensory 
and nutritional quality of our plant foods. A number of biological activities for 
flavonoids have been described extensively in literature113. An isoflavone genistein 
has been shown to block the action of a transcription factor, known as CCAAT 
binding factor neutralizing it before the switch is tripped, so that the cancer cell 
starves, withers and dies. Thus genistein commonly consumed as a component of soya 
bean, is a flavonoid capable of stopping cancer growth and angiogeesis. Crucially, it 
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has no harmful effect on normal healthy cells.114 The estrogenic activity of genistein, 
daidzen and equol are currently being extensively investigated at the molecular, pre-
clinical and clinical levels to determine their potential for treatment of chronic 
diseases such as hormone dependent cancer, cardiovascular diseases and 
osteoporosis.
115
 
Inspired by a broad spectrum of biological activities possessed by flavonoids and a 
rich folklore record of Iris species, we decided for I.ensata and I.hookeriana from 
pharmacological point of view. Detailed literature available on phytochemical 
investigation of the genus116 established the fact that it is a good source of biologically 
active compounds particularly isoflavones. These facts prompted us to undertake Iris 
ensata and Iris hookeriana,the two less explored species of kashmir for the biological 
activity evaluation.  
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Chapter 3 
Bioactivity evaluation 
of extracts of Iris ensata 
 
 
 
 
 
 
 
Kingdom : Plantae 
Subkingdom : Tracheobionta 
Superdivision : Spermatophyta 
Division : Magnoliophyta 
Class  : Liliopsida 
Subclass : Liliadae 
Order  : Liliales 
Family  : Iridaceae 
Genus  : Iris 
Species  : ensata 
 
 
IRIS ENSATA 
Japanese iris or Japanese water iris is a rhizomatous beardless perennnial iris that 
grows in slowly expanding clumps to 2-4′ tall. Sword shaped, linear green leaves (to 
24′′ long) have prominent midribs. Flowers (typically 3-6′′ across) have a distinctively 
flatened appearance. Cultivars come in single, double and peony flowered forms in a 
wide range of colours including shades of blue, lavender, violet-red, pink and white. 
3.1. ANTITUMOR ACTIVITY OF RHIZOMES OF IRIS ENSATA 
The petroleum ether, dichloromethane, ethyl acetate, methanol and methanol water 
extract of rhizomes of Iris ensata were subjected to screening for antitumor activities 
against various human cell lines. The reference compound used was 5-florouracil. 
Results are displayed in table-3.  
 
 
 
 
 
Table 3. Antitumor activity of rhizomes of Iris ensata 
 
 
 
Tissue Type  Leukemia Prostate Colon Lung 
 Cell Line Type  THP-1 PC-3 HCT-15 A549 
S.No. Code Conc. 
(μg/ml) 
% GROWTH INHIBITION 
1.  DCM 100 99±0.02  82±0.07 93±0.04 79±0.02 
2.  DCM 50 91±0.04 59±0.05 85±0.05 62±0.03 
3.       PE 100 37±0.05 67±0.03 79±0.02 62±0.04 
4.       PE 50 18±0.03 32±0.05 54±0.07 34±0.06 
5.  MeW 100 73±0.06 47±0.04 34±0.04 64±0.07 
6.  MeW 50 56±0.05 26±0.03 15±0.06 36±0.05 
7.  MeOH 100 76±0.06 35±0.05 76±0.07 82±0.07 
8.  MeOH 50 49±0.07 15±0.03 52±0.01 76±0.02 
9.  EtOAc 100 93±0.04 47±0.05 63±0.03 78±0.01 
10.  EtOAc 50 73±0.03 26±0.03 35±0.05 62±0.07 
11.  5-FU 1x10-5M 92±0.03 43±0.01 90±0.02 62±0.04 
 
Results and Discussion 
The dichloromethane extract showed the highest %growth inhibition of the cancer cell 
lines followed by the methanol water extract and then petroleum ether extract. The 
dichloromethane extract showed the potency for leukemia, prostate, colon and lung 
cancer whereas methanol water showed potency for leukemia and petroleum ether for 
colon cancer respectively.                                                 
Dichloromethane extract showed the presence of steroids and flavonoids whereas 
methanol water extract contained glycosides. So we could infer that the antitumor 
activity against the cell lines THP-1, PC-3, HCT-15, A549 is possibly due to the 
presence of these compounds either at individual level or through a synergistic mode 
within the class of compounds or between inter class of compounds. The antitumor 
activity of the extracts of Iris ensata is being reported for the first time. 
 
 
3.2. ANTIOXIDANT ACTIVITY OF RHIZOMES OF IRIS ENSATA  
 
 
 
The petroleum ether, dichloromethane, ethyl acetate, methanol and methanol water 
extract of rhizomes of Iris ensata were subjected to screening for antioxidant 
activities against DPPH. The standard used was quercetin. Results are displayed 
below: 
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Table 4. IC50 (µg/ml) values of the extracts of Iris ensata. 
Extract IC50 (µg/ml) 
Standard 2.09 
PE NA 
DCM NA 
EtOAc 49.93 
MeOH 29.18 
MeOH:H2O 31.43 
       
NA: Not Active 
 
 
 
Results and Discussion 
 
 
 
The antioxidant activity performed on the extracts of the rhizomes showed that the 
methanol extract exhibited the highest activity with IC50 equal to 29.18 whereas 
methanol water showed less activity compared to the methanol extract. 
 Ethyl acetate extract also showed some good results. Methanol extract possessed flav
onoids due to which the possible antioxidant activity is reported. The presence of glyc
osides in the methanolwater extract can be attributed to some degree of antioxidant ac
tivity. At higher concentration of the extract the ethylacetate showed the good amount
of antioxidant activity which could be attributed due to the presence of principal class 
of compound present in it such as flavonoids, terpenoids and glycosides. 
3.3. ANTIMICROBIAL ACTIVITY OF RHIZOMES OF IRIS ENSATA  
The petroleum ether, dichloromethane, ethyl acetate, methanol and methanol water 
extract of rhizomes of Iris ensata were subjected to screening for antimicrobial 
activities against various microbial strains. Results are displayed in table-4 
Primary Screening: The samples were tested at 256µg/ml concentration for 
antimicrobial activity. 
Table 5. Antimicrobial activity of rhizomes of Iris ensata 
S.No: 
Tested 
Sample 
S. aureus 
ATCC 
29213 
E. coli 
ATCC 
25922 
C. albicans 
ATCC 90028 
A. 
fumigatus 
1.  DCM Inactive Inactive Inactive Inactive 
2.  MeOH Inactive Inactive Inactive Inactive 
3.  EtOAc Inactive Inactive Inactive Inactive 
4.  PE Inactive Inactive Inactive Inactive 
5.  MeW Inactive Inactive Inactive Inactive 
 
Results and Discussion 
Preliminary screening of the extracts showed no significant antimicrobial activity. 
None of the extracts were potent for the said activity. 
3.4 ANTITUMOR ACTIVITY OF LEAVES OF IRIS ENSATA  
 
 
 
The petroleum ether, dichloromethane, ethyl acetate, methanol and methanol water 
extract of leaves of Iris ensata were subjected to screening for antitumor activities 
against various human cell lines. The reference compound used was 5-florouracil. 
Results are displayed in table-5. 
Table 6. Antitumor activity of leaves of Iris ensata 
Tissue Type 
Breast  Lung   Pancreatic  Prostate  
Cell Line Type MCF-7 A-549 MiaPaca PC-3 
S.No. Code 
Conc. 
(µg/ml) 
% Growth Inhibition 
1.  
PE 
10 57±0.04 28±0.14 33±0.25 8±0.09 
2.  50 67±0.01 44±0.06 41±0.34 22±0.13 
3.  
DCM 
 
10 68±0.01 67±0.23 31±0.42 9±0.04 
4.  50 76±0.03 76±0.08 59±0.18 33±0.04 
5.  
EtOAc 
 
10 53±0.05 26±0.02 21±0.23 4±0.11 
6.  50 83±0.03 29±0.08 36±0.04 13±0.09 
7.  
MeOH 
 
10 8±0.09 21±0.08 18±0.11 7±0.11 
8.  50 11±0.89 62±0.05 54±0.03 17±0.02 
9.  
MeW 
10 6±0.02 15±0.09 40±0.20 60±0.03 
10.  50 59±0.11 26±0.12 68±0.24 98±0.05 
11.  5-FU 20µM - 77±0.09 - 64±0.06 
 
Results and Discussion 
The ethyl acetate and dichloromethane extract showed the highest %growth inhibition 
of the cancer cell lines followed by the methanol water, methanol and petroleum ether 
extract. The dichloromethane extract showed the potency for breast, lung and 
pancreatic cancer whereas ethyl acetate extract showed highest % growth inhibition 
for breast cancer respectively. Methanol extract showed potency for lung and 
 
 
 
pancreatic cancer whereas methanol water showed potency for breast, pancreatic and 
prostate cancer respectively. Petroleum ether showed promising % growth inhibition 
for breast cancer.                                                     
Dichloromethane extract showed the presence of steroids, flavonoids and glycoside 
whereas ethyl acetate extract contained terpenoids in addition to the above mentioned 
principal class of compounds. Methanol and methanol water extract showed the 
presence of terpenoids, flavonoids and glycosides respectively. Petroleum ether 
extract showed the presence of steroids. So we could infer that the antitumor activity 
against the cell lines MCF-7, A-549, MiaPaca, PC-3 is possibly due the presence of 
these compounds giving the results either individually or synergistically.  
The antitumor activity of the extracts of Iris ensata is being reported for the first time. 
The results shown can be utilized for obtaining the corresponding leads so that the 
work done can prove beneficial in the herbal medicine. 
3.5. ANTIOXIDANT ACTIVITY OF LEAVES OF IRIS ENSATA  
The petroleum ether, dichloromethane, ethyl acetate, methanol and methanol water 
extract of leaves of Iris ensata were subjected to screening for antioxidant activities 
against DPPH. The standard used was quercetin. Results are displayed below: 
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Table 7. IC50 (µg/ml) values of the extracts of Iris ensata. 
Extract IC50  (µg/ml) 
 
 
 
 
 
 
 
 
 
 
 
Results and Discussions 
The antioxidant activity performed on the extracts showed that methanol extract 
exhibited the highest activity with IC50 equal to 2.34 almost comparable to that of the 
standard followed by ethyl acetate extract with IC50 equal to 3.24. 
Dichloromethane extract also showed some good results. Methanol extract possessed 
flavonoids and glycosides. Ethyl acetate extract possessed flavanoids besides glycosid
es due to which the possible antioxidant activity is reported. The presence of flavonoi
ds and glycosides as principal class ofcompounds in the dichloromethane extract can 
be attributed to antioxidant activity. At higher concentration of the extract even the  p
etroleum ether showed some antioxidant activity due to expected presence of trace 
amount of these compounds in it. 
3.6. ANTIMICROBIAL ACTIVITY OF LEAVES OF IRIS ENSATA 
The petroleum ether, dichloromethane, ethyl acetate, methanol and methanol water 
extract of leaves of Iris ensata were subjected to screening for antimicrobial activities 
against various microbial strains. Results are displayed in table-6. 
Primary Screening: The samples were tested at 256µg/ml concentration for 
antimicrobial activity 
Results and Discussions 
No significant results could be observed for the extracts subjected for the 
antimicrobial activity. 
Table 8. Antimicrobial activity of leaves of Iris ensata 
 
Standard 2.09 
PE 16.18 
DCM 5.65 
EtOAc 3.24 
MeOH 2.34 
MeOH: Water 36.35 
 
 
 
S.No: 
Tested 
Sample 
S. aureus 
ATCC 29213 
E. coli 
ATCC 25922 
C. albicans 
ATCC 90028 
A. fumigatus 
1. EN/L-Z Inactive Inactive Inactive Inactive 
2. EN/L-Y Inactive Inactive Inactive Inactive 
3. EN/L-X Inactive Inactive Inactive Inactive 
4. EN/L-W Inactive Inactive Inactive Inactive 
5. EN/L-V Inactive Inactive Inactive Inactive 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4 
Bioactivity evaluation of 
extracts of Iris hookeriana 
 
 
 
 
 
 
 
 
 
 
 
 
Kingdom : Plantae 
Subkingdom : Tracheobionta 
Superdivision : Spermatophyta 
Division : Magnoliophyta 
Class  : Liliopsida 
Subclass : Liliadae 
Order  : Liliales 
Family  : Iridaceae 
Genus  : Iris 
Species : hookeriana 
IRIS HOOKERIANA 
Roots slender, fleshy. Rhizome slender, knobbly. Leaves up to 40.0 (2 cm. Peduncle 
(stem) 5-15 (-30) cm. Bracts 4.5-7 cm long. 2-flowered; pedicel very short. Flowers 
blue-purple, with blotches; tube 1.2-3.0 cm long; falls 5-6.5 cm long, c. 2.0 cm broad; 
haft cuneate, blade oblong, beard white, tips coloured. Standard 5.0(2.0 cm, haft 
canaliculate, blade oblong. Filaments blue, as long as creamy anthers. Ovary c. 1.2-
1.3 cm long, trigonal, style sharply keeled, crest triangular; stigma with serrated edge. 
Capsule 5-6 cm long, broadly elliptic, terminating into a conspicuous beak with dried 
flower parts; stipe (1.5-) 2.0-2.5 cm; dehiscence longitudinal. Seeds pyriform, red, aril 
yellowish. 
4.1. ANTITUMOR ACTIVITY OF RHIZOMES OF IRIS HOOKERIANA 
The petroleum ether, dichloromethane, ethyl acetate, methanol and methanol water 
extract of rhizomes of Iris hookeriana were subjected to screening for antitumor 
activities against various human cell lines.The reference compound used was 5-
florouracil. Results are displayed in   table-7. 
Table-9: Antitumor activity of rhizomes of Iris hookeriana 
 
 
 
 
Results and Discussions 
The ethyl acetate extract showed the highest %growth inhibition of the cancer cell 
lines followed by the dichloromethane extract and then petroleum ether extract. The 
ethyl acetate extract showed the potency for leukemia, prostate, colon and lung cancer 
whereas dichloromethane showed potency for prostate, lung and colon and petroleum 
ether for leukemia, colon and lung cancer respectively. Ethyl acetate extract showed 
the presence of terpenoids, flavonoids and glycosides whereas dichloromethane 
extract contained terpenoids and flavonoids. Petroleum ether extract showed the 
presence of steroids and terpenoids. So we could infer from the results of  the 
antitumor activity against the cell lines THP-1, PC-3, HCT-15, A549 is possibly due 
the presence of these compounds giving the results either individually or 
synergistically. The antitumor activity of the extracts of Iris hookeriana is being 
reported for the first time. 
 
 
4.2. ANTIOXIDANT ACTIVITY OF RHIZOMES OF IRIS HOOKERIANA  
Tissue Type  Leukemia Prostate Colon Lung 
 Cell Line Type  THP-1 PC-3 HCT-15 A549 
S.No. Code Conc. 
(μg/ml) 
% GROWTH INHIBITION 
1.  DCM 100 26±0.04 63±0.07 71±0.008 58±004 
2.  DCM 50 13±0.03 40±0.04 55±0.04 32±0.03 
3.  MeOH 100 67±0.03 52±0.05 26±0.03 32±0.04 
4.  MeOH 50 39±0.05 26±0.01 14±0.02 13±0.06 
5.  MeW 100 67±0.02 79±0.05 51±0.05 45±0.02 
6.  MeW 50 36±0.01 58±0.03 22±0.06 21±0.01 
7.  PE 100 82±0.06 25±0.06 92±0.03 69±0.04 
8.  PE 50 59±0.03 11±0.01 87±0.02 45±0.06 
9.  EtOAc 100 78±0.06 97±0.05 98±0.01 89±0.08 
10.  EtOAc 50 54±0.01 93±0.02 92±0.07 60±0.05 
11.  5-FU 1x10-5M 92±0.05 43±0.04 90±0.05 62±0.01 
 
 
 
The petroleum ether, dichloromethane, ethyl acetate, methanol and methanol water 
extract of rhizomes of Iris hookeriana were subjected to screening for antioxidant 
activities against DPPH. The standard used was quercetin. Results are displayed 
below: 
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Table 10. IC50 (µg/ml) values of the extracts of Iris hookeriana rhizomes 
Extract IC50  (µg/ml) 
Standard 2.09 
PE NA 
DCM 21.90 
EtOAc 2.94 
MeOH 11.67 
MeOH: Water 9.26 
 
 
 
Results and Discussion: The antioxidant activity of the extracts showed that ethyl 
acetate extract exhibited the highest activity with to 2.94 which is comparable to that 
 
 
 
 
of the quercetin followed by methanol water extract. Methanol extract also showed so
me significant results. 
The potential antioxidant activity of ethyl acetate extract could mainly be attributed to 
the presence of flavonoids and to some extent to glycosides and terpenoids present in 
it. Same holds true about methanol and methanol water extract. 
4.3. ANIMICROBIAL ACTIVITY OF OF IRIS HOOKERIANA 
The petroleum ether, dichloromethane, ethyl acetate, methanol and methanol water 
extract of rhizomes of Iris hookeriana were subjected to screening for antimicrobial 
activities against various microbial strains. Results are displayed in table-8. 
Primary Screening: The samples were tested at 256µg/ml concentration for 
antimicrobial activity 
Table 11. Animicrobial activity of of Iris hookeriana                
S.No: 
Tested 
Sample 
S. aureus 
ATCC 29213 
E. coli ATCC 
25922 
C. albicans 
ATCC 90028 
A. fumigatus 
1. MeW Inactive Inactive Inactive Inactive 
2. MeOH Inactive Inactive Inactive Inactive 
3. DCM Inactive Inactive Inactive Inactive 
4. EtOAc Inactive Inactive Inactive Inactive 
5. PE Inactive Inactive Inactive Inactive 
Results and Discussion 
All the extracts were inactive towards antimicrobial activity. 
4.5. ANTITUMOR ACTIVITY OF LEAVES OF IRIS HOOKERIANA 
 
 
 
The petroleum ether, dichloromethane, ethyl acetate, methanol and methanol water 
extract of leaves of Iris hookeriana were subjected to screening for antitumor 
activities against various human cell lines. The reference compound used was 5-
florouracil. Results are displayed in   table-9. 
Table 12. Antitumor activity of leaves of Iris hookeriana 
Tissue Type 
Breast  Lung   Pancreatic  Prostate  
Cell Line Type  MCF-7 
A-549 MiaPaca PC-3 
S.No. Code Conc.(µg/ml) 
% growth inhibition 
1.  PE 10 
89±0.05 60±0.14 63±0.01 87±0.02 
2.  50 
99±0.13 81±0.02 79±0.03 98±0.01 
3.  DCM 10 
53±0.08 77±0.04 65±0.06 54±0.05 
4.  50 
96±0.03 97±0.08 95±0.08 77±0.04 
5.  EtOAc 10 
10±0.08 6±0.01 52±0.01 29±0.01 
6.  50 
52±0.89 35±1 80±1 56±1 
7.  MeOH 10 
4±0.08 3±0.09 46±0.24 10±0.09 
8.  50 
10±0.15 13±0.03 55±0.09 68±0.05 
9.  MeW 10 
4±0.04 32±0.08 27±0.01 19±0.02 
10. 50 
10±0.03 65±0.18 40±0.36 52±0.04 
  11. 5-FU 20µM 
- 77±0.09 - 64±0.06 
 
 
 
Results and Discussion 
The petroleum ether and dichloromethane extract showed the highest %growth 
inhibition of the cancer cell lines followed by the ethyl acetate, methanol and 
methanol water extracts. The dichloromethane extract showed the potency for breast, 
 
 
 
lung, pancreatic and prostate cancer whereas ethyl acetate extract showed high % 
growth inhibition for breast, pancreatic and prostate cancer at higher concentration. 
Methanol extract showed potency for pancreatic and prostate cancer whereas 
methanol water showed potency for lung and prostate cancer respectively at higher 
concentration. 
The presence of the principal class of compounds viz. flavonoids, terpenoids and 
glycosides present in these extracts, could be responsible for the reported activities 
either at individual level or through synergistic mode. The dichloromethane extract 
showed the highest possible activity for the cancer cell lines. Petroleum extract is 
equally potent. Therefore further studies on those extracts if undertaken based on the 
isolation and characterization of the compounds can fetch us a good lead so that a 
better pharmacopeia can be added to the literature of the herbal medicine.                                                 
Dichloromethane extract showed the presence of terpenoids and flavonoids whereas 
petroleum ether extract contained steroids and terpenoids as the principal class of 
compounds. Ethyl acetate extract showed the presence of terpenoids, flavonoids and 
glycosides. Methanol and methanol water extracts contained flavonoids and 
glycosides respectively. So we could infer that the antitumor activity against the cell 
lines MCF-7, A-549, MiaPaca, PC-3 is possibly due the presence of these compounds 
giving the results either individually or synergistically.  
The antitumor activity of the extracts of Iris hookeriana is being reported for the first 
time. 
4.4. ANTIOXIDANT ACTIVITY OF LEAVES OF IRIS HOOKERIANA 
The petroleum ether, dichloromethane, ethyl acetate, methanol and methanol water 
extract of rhizomes of Iris hookeriana were subjected to screening for antioxidant 
activities against DPPH. The standard used was quercetin. Results are displayed 
below: 
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Table 13. IC50 (µg/ml) values of the extracts of Iris hookeriana leaves 
 
 
 
 
 
 
Results and Discussion 
The antioxidant activity performed on the extracts showed that methanol water extract 
exhibited the highest activity followed by methanol extract. Dichloromethane and 
ethyl actetate extract also showed some amount of activity. 
Methanol water extract possessed flavonoids and their glycosides due to which the  po
ssible antioxidant activity is reported. The presence of flavonoids and glycosides as pr
incipal class of compounds in the methanol extract as well can be attributed to  antioxi
dant activity. At higher concentration of the extract, the dichloromethane and ethyl 
Extract IC50  (µg/ml) 
Standard 2.09 
PE NA 
DCM 62.64 
EtOAc 67.45 
MeOH 41.27 
MeOH: Water 38.26 
 
 
 
acetate extract showed some amount of antioxidant activity presumably due to the 
lower concentration of flavonoids and their glycosides respectively. 
4.5. ANTIMICROBIAL ACTIVITY OF LEAVES OF IRIS HOOKERIANA.  
The petroleum ether, dichloromethane, ethyl acetate, methanol and methanol water 
extract of rhizomes of Iris hookeriana were subjected to screening for antimicrobial 
activities against various microbial strains. Results are displayed in table-10. 
Primary Screening: The samples were tested at 256µg/ml concentration for 
antimicrobial activity.  
Table 14. Antimicrobial activity of leaves of Iris hookeriana.  
S.No: 
Tested 
Sample 
S.aureus 
ATCC 
29213 
E.coli 
ATCC 
25922 
C.albicans 
ATCC 90028 
A.fumigatus 
1. PE Inactive Inactive Inactive Inactive 
2. DCM Inactive Inactive Inactive Inactive 
3. EtOAc Inactive Inactive Inactive Inactive 
4. MeOH Inactive Inactive Inactive Inactive 
5. MeW Inactive Inactive Inactive Inactive 
                                      
Results and Discussion 
No antimicrobial activity could be observed for the extracts. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 5 
Experimental 
 
 
 
 
 
 
 
5. EXPERIMENTAL WORK: 
Collection of the plant material 
The plant material was collected during their blooming seasons respectively. Iris 
ensata was collected from Pantha Chowk area of the Valley during the month of May 
and was identified by the Institute of Plant taxanomy, university of kashmir and was 
registered under vocher number 35606(KASH). Iris hookeriana was collected from 
Doodpathrie area of the Valley during the month of June and was identified by the 
Istitute of Plant taxanomy, university of kashmir and was registered under vocher 
number 1210(KASH). 
Drying of plant material 
The plant material obtained was subsequently separated into its different parts viz, 
rhizomes, leaves and flowers respectively. The plant parts were shade dried. 
Pulverization of different parts of the plants 
The dried plant material was then pulverized partwise and extracted separately using 
soxhlet apparatus with solvents of increasing polarity starting from pet ether, 
dichloromethane, ethyl acetate, methanol to methanol water for different time periods. 
PLANT PART: RHIZOMES 
The rhizome part of Iris ensata and Iris hookeriana was subjected to soxhlet 
extraction with following solvent system for the given period of time. The respective 
extracts were dried with rotavapour. The time period and the yields obtained are 
tabulated as under. 
Table 15. Yield of extracts of rhizomes. 
Extracts Iris ensata 
Time/weight of the residue 
Iris hookeriana 
Time/weight of the residue 
Pet ether 8 hours/8.7 gms 12 hours/5.34 gms 
DCM 11 hours/5.57 gms 28 hours/64.6 gms 
Ethyl acetate 13 hours/5.4 gms 40 hours/31.98 gms 
Methanol 17 hours/27.36 gms 48 hours/169.74 gms 
 
 
 
Methanol water 13 hours/13 gms 32 hours/110.02 gms 
 
Table 16. Qualitative Chemical analysis.  
 
Observation based on chemical analysis: 
Qualitative chemical tests performed on the extracts of the rhizomes of Iris ensata and 
Iris hookeriana showed the presence of different principal class of compounds present 
in them. 
The petroleum ether extract of iris ensata showed the presence of steroids. The 
dichloromethane extract showed the presence of steroids and flavonoids. The ethyl 
acetate extract showed the presence of steroids, terpenoids, flavonoids and their 
glycosides. The methanol extract contained flavonoids and methanol water extract 
contained glycosides respectively. 
Similarly the petroleum ether extract of rhizomes of iris hookeriana showed the 
presence steroids and terpenoids. The dichloromethane extract showed the presence of 
terpenoids and flavonoids. The ethyl acetate extract showed the presence of 
terpenoids, flavonoids and their glycosides. The methanol extract contained 
terpenoids, flavonoids and their glycosides. The methanol water extract contained 
flavonoids and glycosides respectively. 
PLANT PART : LEAVES 
Extracts Steroids Terpenoids Flavanoids Glycosides Alkaloids 
Pet ether 
Ie/Ih 
positive/ 
positive 
negative/ 
positive 
negative/ 
negative 
negative/ 
negative 
negative 
negative/ 
DCM 
Ie/Ih 
positive/ 
negative 
negative/ 
positive 
positive/ 
positive 
negative/ 
negative 
negative/ 
negative 
Ethyl acetate 
Ie/Ih 
positive/ 
negative 
positive/ 
positive 
positive/ 
positive 
positive/ 
positive 
negative/ 
negative 
Methanol 
Ie/Ih 
negative/ 
negative 
negative/ 
positive 
positive/ 
positive 
negative/ 
positive 
negative/ 
negative 
Methanol:water 
Ie/Ih 
negative/ 
negative 
negative/ 
negative 
negative/ 
positive 
positive/ 
positive 
negative/ 
negative 
 
 
 
The leaves part of Iris ensata and Iris hookeriana was subjected to soxhlet extraction 
with following solvent system for the given period of time. The respective extracts 
were dried with rotavapour.The time period and the yields obtained are tabulated as 
under: 
Table 17. Yield of extracts of leaves. 
Extracts Iris ensata 
Time/weight of the residue 
Iris hookeriana 
Time/weight of the residue 
Pet ether 4 hours/12.67 gms 10 hours/16.34 gms 
DCM 16 hours/7 gms 5 hours/8.6 gms 
Ethyl acetate 5 hours/10 gms 10 hours/11.98 gms 
Methanol 13 hours/27.36 gms 11 hours/60.74 gms 
Methanol:water 5 hours/13 gms 5 hours/11.02 gms 
 
Table 18. Qualitative chemical analysis  
Extracts Steroids Terpenoids Flavanoids Glycosides Alkaloids 
Pet ether 
Ie/Ih 
Positive/ 
Positive 
Negative/ 
Positive 
Negative/ 
Negative 
Negative/ 
Negative 
Negative/ 
Negative 
DCM 
Ie/Ih 
Positive/ 
Negative 
Negative/ 
Positive 
Positive/ 
Positive 
Positive/ 
Negative 
Negative/ 
Negative 
Ethyl acetate 
Ie/Ih 
Positive/ 
Negative 
Positive/ 
Positive 
Positive/ 
Positive 
Positive/ 
Positive 
Negative/ 
Negative 
Methanol 
Ie/Ih 
Negative/ 
Negative 
Positive/ 
Negative 
Positive/ 
Positive 
Positive/ 
Positive 
Negative/ 
Negative 
Methanol 
water 
Ie/Ih 
Negative/ 
Negative 
Positive/ 
Negative 
Positive/ 
Positive 
Positive/ 
Positive 
Negative/ 
Negative 
 
 
Observation based on chemical analysis:  
Qualitative chemical tests performed on the extracts of the rhizomes of Iris ensata and 
Iris hookeriana showed the presence of different principal class of compounds present 
in them. 
 
 
 
The petroleum ether extract of leaves of Iris ensata showed the presence of steroids. 
The dichloromethane extract showed the presence of steroids, flavonoids and 
glycosides. The ethyl acetate extract showed the presence of steroids, terpenoids, 
flavonoids and glycosides. The methanol and methanol water extracts contained 
terpenoids, flavonoids and glcosides respectively. 
Similarly the petroleum ether extract of leaves of Iris hookeriana showed the presence 
steroids and terpenoids. The dichloromethane extract showed the presence of 
terpenoids and flavonoids. The ethyl acetate extract showed the presence of 
terpenoids, flavonoids and glycosides. The methanol extract contained flavonoids and 
glycosides. The methanol water extract also contained flavonoids and glycosides 
respectively. 
ANTI-TUMOR ACTIVITY:  
Cytotoxicity assay by Sulphorhodamine B Dye (SRB): 
SRB assay is a rapid, sensitive and inexpensive method for measuring the cytotoxic 
potential of test substances, based on the cellular protein content of adhered 
suspension cultures in 96 well plates. 
This method is suitable for ordinary laboratory purposes and for large-scale 
applications like high through put in vitro screening in anticancer drug discovery. The 
anticancer activity was determined by the cytotoxic potential of the test material using 
human cancer cell line, which was allowed to grow on tissue culture plate in the 
presence of test material. The cell growth was measured on ELISA reader after 
staining with Sulphorhodamine B (SRB) dye which binds to basic amino acid residues 
in trichloroacetic acid (TCA) fixed cells 
Principle of assay: 
1. SRB is an anionic bright pink amino xanthene protein dye with two sulfonic 
groups. Its molecular formula and molecular weight are C27H30N2O7S2 and 558.66 
respectively. 
2. The SRB assay is based on the ability of the SRB dye to bind electrostatically and 
pH dependent on protein basic amino acid residues. Under mild acidic conditions, 
SRB binds to protein basic amino acid residues of trichloroacetic acid (TCA)–
fixed cells. It can be quantitatively extracted from cells and solubilized for optical 
densitiy (OD) measurement by weak bases such as tris base. 
 
 
 
3. Color development in SRB assay is rapid, stable and visible. The end point of the 
SRB assay is colorimetric, nondestructive, and indefinitely stable. The SRB 
staining method is nondestructive in the sense that it is not necessary to digest 
samples. 
The method appears to offer several advantages over the 3-(4,5-dimethylthiazolyl-
2)-2,5-diphenyltetrazolium bromide (MTT) and 2,3-bis(2-methoxy-4-nitro-5-
sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assays- other cytotoxicity 
assays. It is simpler, faster and more sensitive than the MTT assay, provides better 
linearity with cell number, permits the use of saturating dye concentrations and is 
less sensitive to environmental fluctuations. It is independent of intermediatory 
metabolism and provides a fixed end point that does not require a time sensitive 
measurement of initial reaction velocity. 
Procedure: 
1. The plates were taken out from the incubator after 48 h of adding test samples. 
2. To stop the reaction, 50µl of chilled 50% TCA (trichloroacetic acid) to each 
well of the plate was added, making final concentration to 10%.  
3. Incubated the plates at 4C for 1h to fix the cells attached to bottom of the 
wells. 
4. Washed the plates 5-6 times with distilled water. 
5. Plates were air-dried. 
6. Added 100 µl of SRB dye (0.4% in 1%acetic acid) to each well of the plate 
and left the plates at room temperature for 30 min. 
7. Washed the plates with 1% acetic acid after 30 min. 
8. Plates were again air-dried. 
9. Added 100µl of tris buffer (10.5 M) to each well. 
10. Shaked the plates gently for 10-15 minutes on a mechanical shaker. 
11. Recorded the optical density with ELISA reader at λ= 540nm.  
Calculations: 
The viability and growth in the presence of test material is calculated as 
OD change = Mean of OD of test sample – mean of OD of blank 
 
 
 
% Growth in presence of the control = 100/OD change in presence of control 
% Growth in the presence of test sample = (% growth in presence of control) X  
                                                                      (OD change in presence of test sample) 
% Inhibition by the test sample = 100 - % growth in the presence of test sample 
 
    growth in presence of test material 
      % Inhibition by the Test sample = ---------------------------------------------- X    100 
                   growth in absence of test material 
T / C value for 50% growth inhibition for each test material is calculated from its 
three concentrations. The plant extract showing >70% growth inhibition at 100ug/ml 
and compound (small molecule) showing >50% growth inhibition at 1X10-5 M is 
considered to be active. 
ANTIOXIDANT ACTIVITY: 
Scavenging free radical potentials were tested in a methanolic solution of DPPH. The 
degree of decoloration of the solution indicates the scavenging efficiency of the added 
extract. To a 100 micro molar solution of DPPH, 0.01-0.15ml of 5mg/ml extract was 
added. Sixty minutes later, the absorbance was measured at 517 nm. The antiradical 
activity was calculated as a percentage of DPPH decoloration using the following 
equation: 
Antiradical activity =100 × (1 - absorbance of sample/absorbance of reference) 
 
 
 
ANTI-MICROBIAL ACTIVITY:  
Antibacterial activity assay : 
The extracts prepared were tested against the following bacterial strains: Gram 
positive Staphylococcus aureus ATCC 29213, Gram negative Escherichia coli ATCC 
25922 . The bacterial cultures were maintained on Tryptone soya agar and stored at 
70°C containing 50% glycerol. Ciprofloxacin obtained from Sigma-Aldrich was used 
as standard antibacterial agent for this study. Stock solution was prepared at 1mg/ml.. 
Bacterial suspensions were prepared by suspending 18-24 hrs grown bacterial cultures 
in sterile normal saline. The turbidity of the bacterial suspension was adjusted to 0.5 
 
 
 
McFarland standards (equivalent to 1.5 × 108 CFU/ml) at wavelength 625nm. The 2-
fold serial of compounds and extracts (stock solution prepared in DMSO) were 
prepared in MHB (Mueller Hinton Broth; DIFCO laboratories) in 100μl volume in 
96-well U bottom microtitre plates (Tarson, Mumbai, India). The above mentioned 
bacterial suspensionwas further diluted in the MHB and 100μl volume of this diluted 
inoculum was added to each well of the plate resulting in the final inoculum of 5 × 
105 CFU/ml in the well and the final concentrations of the samples ranged from 2000 
to 3.90μg/ml till the 10th column. Column 11 and column 12 containing 100μl and 
200μl of medium without drug served as growth and media control respectively. The 
plates were incubated at 37°C for 18 hrs and were read visually and the minimum 
concentration of the compound showing no turbidity was recorded as MIC. 
Antifungal activity assay : 
The disc diffusion method was used to determine the antifungal activity of the 
extracts using Sabouraud Dextrose Agar (SDA) (Hi-Media). The SDA plates were 
prepared by pouring 15ml of SDA into sterile Petri plates. The plates were allowed to 
solidify for 15 minutes and 0.1 ml (0.5 McFarland) inoculum suspension was 
swabbed uniformly and the plates were allowed to dry for 5 -10 minutes. 50 μg of the 
different extracts was loaded on 6 mm sterile discs (Hi Media). The loaded discs were 
placed on the surface of the medium and the samples were allowed to diffuse for 5 
minutes and the plates were kept for incubation. Inhibition zones formed around the 
discs were measured with transparent ruler (in mm). Antibiotic disc (Nystatin) and 
solvent (methanol) were taken as positive and negative controls respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 6 
Isolation & characterization of 
Ih/DC and  
Ih/DC-2 
 
 
6. ISOLATION OF Ih/DC AND Ih/DC-2 
 
 
 
During soxhlet extraction of rhizomes of Iris hookeriana with dichloromethane 
for 18 hrs a residue was left out (8gm). On checking its purity on TLC it showed 
a multispot behaviour. On treating  it with different solvents of varying polarity 
to carry out its crystallisation, two compounds were obtained. One of them was  i
dentified as 3′,5-dihydroxy 4′,5′,6,7-tetramethoxy isoflavone commonly known  a
s irigenin and another one was identified  as 5′-hydroxy,3′,4′-dimethoxy-6,7-
methylenedioxy isoflavone. 
CHARACTERISATION OF Ih/DC  
The compound Ih/DC was isolated as yellow needles (MeOH), m.p. 186-187 °C. The 
mass spectrum showed molecular ion peak at M
+
 374 analysed for C19H18O8 that 
showed a molecular ion peak at m/z 374[M+1].  The UV spectrum showed absorption 
bands at λmax 201, 265, and 323 nm, suggesting its isoflavone nature, further 
confirmed by the singlet signal at δH 8.42 for H-2 in its 1HNMR spectra. The IR 
spectrum showed absorption bands at 3437, 2956, 1651, and 1065 cm
−1
, indicating the 
presence of O-H, aromatic C-H, α ,β-unsaturated carbonyl, and C-O functions in the 
molecule. The 
1
H-NMR spectrum showed resonances for 18 protons; three aromatic 
protons signals at δH 8.42 (s, H-2), 6.61 (s, H-8), 6.75 (d, J = 1.5 Hz, H-2', 6'), four 
methoxy group signals at δH 3.70 (4'-OCH3), 3.76 (6-OCH3), 3.79 (5'-OCH3), and 
3.88 (7-OCH3), 3' and 5 chelated hydroxy groups at δH 9.31 and 12.97.The 
13
CNMR 
showed nineteen carbon signals, The placement of the methoxy groups at C-4', C-6, 
C-5', and C-7 was supported by the spectrum that displayed correlations between 4'-
OCH3 and C-4' (δC 136.1), 6-OCH3 and C-6 (δC 132.1), 5'-OCH3 and C-5' (δC 
152.2), as well as 7-OCH3 and C-7 (δC 154.5). On the basis of the above evidences, 
the structure of Ih/DC was elucidated as 3',5-dihydroxy-4',5',6,7-
tetramethoxyisoflavone (irigenin). 
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CHARACTERISATION OF Ih/DC-2 
The compound Ih/DC-2 derived as yellow amorphous solid from the dichloromethane 
extract of Iris hookeriana, m.p. 174ºC. The mass spectrum showed ion peak M
+
 at 
 
 
 
358 analysed for C18H14O8 .   The compound exhibited UV absorption at 270 and 340 
nm characteristic of an isoflavonoid. IR absorption bands were found at 3240 (OH), 
1660 (C=O), 1610 (C=C) 940 cm
-1
 (methylenedioxy) and sharp two proton singlet at 
δ 6.2 in the 1HNMR spectrum, which showed additionally two low field singlets at δ 
9.1 and 12.9 characteristic for the hydroxyl proton at position 3′ and 5 respectively. 
Chemical shifts of two singlet signals for the H-2 and H-8 protons fell in the normal 
shift region for the isoflavonoid nucleus. The 3′4′5′ oxygenation pattern of ring C 
could be derived from the two meta coupled doublets at δ 6.58 and 6.83. Methylation 
of the free hydroxyl groups gave a product with mp and 
1
HNMR data identical with 
those reported for irisflorentin (5,3′,4′,5′-tetramethoxy-6,7methylenedioxyisoflavone). 
The 
13
CNMR showed 18 carbon signals. Having the same basic skeleton as that of the 
irigenin the differentiating signal is at 102.32 corresponding to O_CH2_O. Therefore 
the structure of Ih/DC-2 got confirmed as 5,3′-dihydroxy-4′,5′-dimethoxy-6,7-
methylenedioxyisoflavone. 
 
 
            
6.1. SAR STUDIES OF Ih/DC VIS-À-VIS ANTITUMOR ACTIVITY 
In order to carry out some SAR studies, the irigenin was subjected to acetylation and 
methylation and two compounds obtained were subjected for antitumor activity vis a 
vis the irigenin and the result obtained is given below:  
GENARAL PROCEDURE FOR ACETYLATION 
20-25 mg of the compound dissolved in C5H5N (5ml) was treated with Ac2O (2ml) 
and left for 24-48 hrs. The reaction was monitored by TLC. The acetates were treated 
with acidulated water; the ppt. was filtered, dried and dissolved in CHCl3. The 
mixture was separated by column chromatography using petrol: benzene (3:7) and the 
acetates were crystallized from CHCl3-MeOH. 
GENERAL PROCEDURE FOR METHYLATION 
O
OH O
 5'-hydroxy,3',4',-dimethoxy-6,7-
methylenedioxy isoflavone.
O
O
OH
OCH3
OCH3
 
 
 
 20-30 mg of the compound was dissolved in dry MeOH (25-40 ml) and anhydrous 
K2CO3 (0.5-1gm) was added to the solution. The MeI (5ml) was now added dropwise 
with constant shaking to the solution. The mixture was refluxed on water bath for 2 
hrs, filtered and freed from solvent and crystallized from C6H6-MeOH. 
RESULTS OF SAR STUDIES: 
The parent compound, irigenin possessed the significant antitumor activity against 
leukemia, lung and colon cancer respectively. On methylation the %growth inhibition 
got increased for leukemia, lung and liver cancer cell lines whereas the activity got 
decreased for colon cancer at higher concentration but at lower concentration it 
showed an increase in the activity. The acetylated irigenin showed an overall decrease 
in the % growth inhibition of all the cancer cell lines respectively. It could be inferred 
that length of carbon chain has a pivotal role in the antitumor activity of the 
compound. These results reveal that for better activity the optimum length of the 
carbon chain of the substituents should not exceed beyond two carbon atoms. 
The standards used in carrying out SAR studies vis a vis antitumor activity were 5-
FU, Paclitaxel and Mito-C respectively. 
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Table 19: Anticancer activity of Irigenin and its acetylated and methylated derivative 
 
 
 
LIVER LUKEUMIA LUNG COLON 
 HEP-2 THP-1 A-549 COLO-205 
 
 
 
 
Code Conc.(ug/ml)  % GROWTH INHIBITION 
Ih/DC 100 57±0.05 81±0.03 78±0.02 86±0.06 
 50 28±0.04 65±0.04 51±0.03 49±0.03 
Ih-I 100 69±0.01 91±0.05 84±0.05 78±0.05 
 50 38±0.03 56±0.01 45±0.04 51±0.03 
Ih-II 100 36±0.04 50±0.02 35±0.06 43±0.05 
 50 05±1 26±0.03 12±0.03 13±0.02 
5-FU 1x10-5 23±0.08 38±0.05 20±0.03 78±0.01 
Paclitaxel 1x10-5 28±0.06 45±0.06 79±0.08 15±0.03 
Mito-C 1x10-5 89±0.05 43±0.05 37±0.05 12±0.04 
 
Ih/DC is irigenin 
Ih-I is methylated irigenin 
Ih-II is acetylated irigenin 
 
 
 
 
 
 
 
 
 
 
 
Summary 
 
 
 
 
 
PLANT PART: RHIZOMES 
 
 
 
Comparative antitumor activity of extracts of rhizomes of Iris ensata and Iris 
hookeriana. 
SulphaRhodamine B assay (SRB) was performed which revealed increase in growth 
inhibition during 48h incubation against a panel of human cancer cell lines. The 
increase in growth inhibition depicted that the incubation of the cells for 48h with the 
test material (DCM) at 100 and 50μM concentration resulted in growth inhibition of 
leukemia (THP-1), prostate (PC-3), colon (HCT-15) and lung (A549) cancer cell 
lines. Interestingly, leukemia was showing promising inhibition compared to rest of 
the cell lines tested. Ethyl acetate extract of Iris hookeriana exhibited promising 
inhibition among all the cell lines tested for anti-cancer activity. Taken together, the 
results depicted that the incubation of different human cancer cell lines of varied 
tissue origin even with 50μM of dichloromethane extract of Iris ensata and ethyl 
acetate extract of Iris hookeriana for 48h imparted cytotoxic effects on cellular 
cytotoxicity to a great extent.                          
Comparative antioxidant activity of extracts of rhizomes of Iris ensata and Iris 
hookeriana  
DPPH radical scavenging activity showed Iris hookeriana to be more potent than Iris 
ensata. The IC50 of ethyl acetate extract of Iris hookeriana equal to 2.94 which was 
almost comparable with the IC50 of the quercetin used as a standard. Methanol and 
methanol water extracts of rhizomes of Iris hookeriana also showed some amount of 
antioxidant activity. 
Comparative antimicrobial activity of rhizomes of Iris ensata and Iris 
hookeriana. 
All the extracts of the two species showed no significant activity towards inhibition of 
microbial growth. Preliminary screening of the extracts of the two species for the 
microbial strains S. aureus 29213, E. coli ATCC 25922, C. albicans ATCC 90028 and 
A. fumigatus showed the extracts to be inactive. 
 
 
PLANT PART: LEAVES 
Comparative antitumor activity of extracts of leaves of Iris ensata and Iris 
hookeriana 
 
 
 
Sulpharhodamine B assay (SRB) was performed which revealed increase in growth 
inhibition during 48h incubation against a panel of human cancer cell lines. The 
increase in growth inhibition depicted that the incubation of the cells for 48h with the 
test material containing petroleum ether and dichloromethane extracts of leaves of Iris 
hookeriana at 10 and 50μM concentration resulted in growth inhibition of breast 
(MCF-7), pancreatic Miapaca, prostate (PC-3) and lung (A549) cancer cell lines. 
Dichloromethane extract and Ethyl acetate extract of Iris ensata exhibited promising 
inhibition for breast (MCF-7) and lung (A-549) cell lines at lower concentration. 
Whereas methanol water extract showed promising results for prostate (PC-3) cell 
line. Taken together, the results depicted that the incubation of different human cancer 
cell lines of varied tissue origin even with 50μM of methanol water and ethyl acetate 
extract of Iris ensata and petroleum ether and dichloromethane extract of Iris 
hookeriana for 48h imparted cytotoxic effects on cellular cytotoxicity to a great 
extent.                         
 Comparative antioxidant Activity of extracts of leaves of Iris ensata and Iris 
hookeriana 
DPPH radical scavenging activity showed Iris ensata to be more potent than Iris 
hookeriana. The IC50 of methanol extract of Iris ensata equal to 2.34 which was 
almost comparable with the IC50 of the quercetin  used as a standard. The ethyl acetate 
and dichloromethane extracts of Iris ensata possessed IC50 equal to 3.24 and 5.65 
respectively whereas extracts of Iris hookeriana showed higher values of IC50 
compared to the extracts of Iris ensata thereby concluding Iris ensata to be more 
potent antioxidant than Iris hookeriana. 
Comparative antimicrobial activity of extracts of leaves of Iris ensata and Iris 
hookeriana 
All the extracts of the two species showed no significant activity towards inhibition of 
microbial growth. Preliminary screening of the extracts of the two species for the 
microbial strains S. aureus 29213, E. coli ATCC 25922, C. albicans ATCC 90028 and 
A. fumigatus showed the extracts to be inactive. 
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Appendix I  :  List of Symbols/Abbreviations 
ATCC    American Type Culture Collection 
CC    Column chromatography 
CDCl3    Deuterated Chloroform  
CFU    Colony forming units 
cm
-1
    Centimeter inverse 
°C    Degree Celsius 
d    Doublet 
DMSO (d6)   Deuterated dimethyl sulphoxide 
ESI-MS   Electrospray Ionization Mass Spectrometry 
Fig.    Figure 
g/gm    Gram 
Hz    Hertz 
IR    Infrared 
J    Coupling constant 
m    Multiplet 
M    Molecular mass 
MeOD    Deuterated Methanol 
mg     Milligram 
μg     Microgram 
MHz                                        Mega Hertz 
MIC    Minimum inhibitory concentration 
mM    Millimolar 
M.p.    Melting point 
m/z    Mass to Charge ratio 
 
 
 
Na    Sodium 
NAM    Nutrient agar medium 
NBGP Nutrient broth containing 0.05% phenol red and 
supplemented with 10% glucose 
NMR    Nuclear Magnetic Resonance  
OD    Optical density 
ppm    Parts Per Million 
RA    Reference antibiotic 
Rf    Retention factor 
s     Singlet 
TLC    Thin Layer Chromatography 
UV    Ultra Violet 
v/v    Volume by Volume 
α     Alpha 
β     Beta 
δ     Delta 
λmax     Lamda maximum 
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Appendix IV:  PHYTOCHEMICAL TESTS 
                          
 
 
 
1. Test for Steroids: In a small quantity of petroleum ether extract, 2ml of acetic 
anhydride solution was added in CHCl3. This was followed by addition of 
conc.H2SO4. A greenish colour was produced which turns to blue indicates the 
presence of steroids. 
2. Test for Flavonoids: Dilute ammonia (5ml) was added to a portion of an aqueous 
filtrate of the extract, concentrated sulphuric acid (1ml) was added. A yellow 
colouration that disappears on standing indicates the presence of flavonoids. 
3. Test for terpenoids: To 0.5gm of the methanolic extract was added 2ml of 
chloroform. Concentrated sulphuric acid (3ml) was carefully added to form a layer. A 
reddish brown colouration of the interface indicates the presence of terpenoids. 
4. Test for Glycosides: A small quantity of the extract was dissolved in 1ml of water. 
Sodium hydroxide solution was added, yellow colour appeared that indicates the 
presence of glycosides. 
5. Test for Alkaloids: Few mg of methanolic extract was dissolved in 5ml of distilled 
water. 2ml hydrochloric acid was added until an acid reaction occurs then 1ml of 
Dragendroffs reagent was added, orange red precipitate was formed immediately 
indicated the presence of alkaloids. 
 
 
 
 
 
 
 
 
 
 
Appendix V:  SPRAY REAGENTS 
1. Anisaldehyde-sulphuric acid reagent: 0.5 ml of anisaldeyde is mixed with 10 ml 
glacial acetic acid, followed by 85 ml methanol and 5 ml conc. H2SO4 
 
 
 
2. Cerric ammonium sulphate reagent: To 6gms of cerric ammonium sulphate 3ml 
of sulphuric acid was added and the final volume of the solution was made to 100 ml 
with distilled water. 
3. Ferric chloride reagent: To 5 % solution of FeCl3, NH4OH solution is added with 
shaking drop by drop till the permanent precipitate is obtained (or) 1% Ferric (III) 
Chloride in Methanol/water (1:1). 
4. Dragendroffs reagent: 
Solution a: 0.85 gm of  basis bismuth nitrate was dissolved in a mixture of 10 ml 
acetic acid and 40 ml water. 
Solution b: A solution was made by dissolving 8 gms of potassium iodide in 20 ml 
water. 
Stock solution: Equal volumes of a and b were mixed. 
Spray reagent: 1 ml stock solution was mixed with 2 ml acetic acid and 10 ml water 
before use. 
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